data_2mg1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mg1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -54.78 -46.32 74.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.698 1.599 . . . . 0.0 112.968 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.76 -45.12 91.24 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.932 0.893 . . . . 0.0 111.87 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.06 -50.08 74.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.385 0.539 . . . . 0.0 111.763 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -58.08 -37.32 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.213 1.405 . . . . 0.0 110.852 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.6 mtt -61.95 -44.32 97.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.83 1.196 . . . . 0.0 112.228 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.46 -53.71 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.025 0.93 . . . . 0.0 110.729 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.38 -27.98 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.23 -40.61 99.25 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.532 1.539 . . . . 0.0 112.989 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.16 94.35 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 118.04 0.92 . . . . 0.0 112.256 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 125.552 1.541 . . . . 0.0 112.233 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.75 -44.58 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.055 0.942 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.5 -45.79 92.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.495 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.4 81.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.363 0.665 . . . . 0.0 112.104 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.18 -39.97 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.072 0.949 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.24 -42.64 99.24 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.798 -1.189 . . . . 0.0 111.992 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -63.26 -51.53 65.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 112.193 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -64.41 -31.63 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.308 -0.87 . . . . 0.0 112.653 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -34.85 76.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.827 1.251 . . . . 0.0 112.561 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 124.259 1.024 . . . . 0.0 112.659 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -52.66 -41.32 63.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.929 1.291 . . . . 0.0 113.003 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.83 -47.7 65.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.111 1.764 . . . . 0.0 111.651 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.79 -49.33 76.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.388 0.54 . . . . 0.0 111.96 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.37 -37.11 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 111.167 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -43.33 97.5 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.426 1.012 . . . . 0.0 112.801 175.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.85 -53.67 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.481 0.712 . . . . 0.0 110.846 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.99 -34.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.018 0.527 . . . . 0.0 112.4 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.53 77.48 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.426 1.489 . . . . 0.0 113.838 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.85 -56.59 12.16 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.058 0.929 . . . . 0.0 111.6 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 125.397 1.479 . . . . 0.0 113.629 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -57.44 -40.35 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.858 0.863 . . . . 0.0 111.954 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -43.24 91.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.137 0.975 . . . . 0.0 112.277 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.56 84.86 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.794 0.838 . . . . 0.0 111.591 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.97 -41.16 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.83 -43.43 94.58 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.905 -1.122 . . . . 0.0 112.007 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 t -67.32 -48.14 68.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.589 0.756 . . . . 0.0 112.394 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.9 tt -64.15 -31.86 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.372 -0.83 . . . . 0.0 112.453 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -61.49 -40.51 94.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.27 0.941 . . . . 0.0 112.531 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.5 mttt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 175.101 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -53.98 -42.95 69.55 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.572 1.549 . . . . 0.0 113.056 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.58 -47.93 83.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.287 1.035 . . . . 0.0 112.156 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.09 -51.75 68.7 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.915 -0.491 . . . . 0.0 111.65 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -54.86 -39.51 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.547 1.539 . . . . 0.0 111.276 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -48.84 80.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.186 0.995 . . . . 0.0 111.989 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.3 mt -65.13 -53.82 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 110.977 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -69.28 -34.04 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.62 90.42 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.701 1.619 . . . . 0.0 112.897 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -49.32 59.82 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.273 1.037 . . . . 0.0 111.049 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 126.062 1.745 . . . . 0.0 113.371 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.8 -40.58 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.738 . . . . 0.0 111.701 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -61.58 -38.32 87.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.358 1.063 . . . . 0.0 112.468 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.55 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.425 0.69 . . . . 0.0 111.349 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.1 -42.3 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.607 1.163 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.84 -39.88 95.72 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.747 -1.221 . . . . 0.0 112.302 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.27 -51.44 60.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.268 1.027 . . . . 0.0 112.136 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.8 -34.4 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.289 -0.882 . . . . 0.0 112.546 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -56.33 -31.76 64.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.978 1.311 . . . . 0.0 113.585 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.9 tttm . . . . . 0 N--CA 1.474 0.764 0 C-N-CA 124.807 1.243 . . . . 0.0 113.779 177.742 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tptm . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -52.69 -43.46 65.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.497 1.519 . . . . 0.0 113.032 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -64.6 -46.52 82.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 111.509 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -56.59 -50.75 71.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.999 0.519 . . . . 0.0 111.472 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.21 -42.82 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.443 1.097 . . . . 0.0 111.07 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.84 -44.81 93.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.41 1.005 . . . . 0.0 112.815 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.96 -53.78 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.857 0.863 . . . . 0.0 111.159 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.0 m -69.39 -24.78 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.64 -31.18 66.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.39 1.472 . . . . 0.0 113.54 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.25 75.79 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.391 1.095 . . . . 0.0 111.734 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 125.421 1.488 . . . . 0.0 112.992 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.93 -41.56 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.829 0.852 . . . . 0.0 111.78 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.89 -40.61 96.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.851 0.86 . . . . 0.0 112.685 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.83 91.75 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.734 -0.604 . . . . 0.0 111.673 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.73 -42.38 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.792 0.837 . . . . 0.0 111.962 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.01 -33.97 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.527 -1.358 . . . . 0.0 113.371 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -72.34 -50.94 23.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.095 0.958 . . . . 0.0 111.782 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.62 -31.69 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.244 -0.91 . . . . 0.0 112.951 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -58.52 -30.89 67.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.921 -1.112 . . . . 0.0 113.721 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mttp . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 175.079 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -52.33 -53.79 39.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.268 1.427 . . . . 0.0 111.862 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.96 -45.99 89.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.45 1.5 . . . . 0.0 112.032 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -55.25 -50.09 70.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.376 0.671 . . . . 0.0 111.504 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mt -58.16 -38.15 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.678 1.191 . . . . 0.0 111.315 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.9 mtp -64.98 -43.5 92.4 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.476 1.035 . . . . 0.0 112.643 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.26 -53.71 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.971 0.908 . . . . 0.0 110.723 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.03 -26.84 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.4 -37.0 79.45 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.567 1.556 . . . . 0.0 113.022 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.97 -51.87 55.87 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.671 0.736 . . . . 0.0 111.404 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 126.177 1.791 . . . . 0.0 113.348 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.2 -45.23 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.303 1.041 . . . . 0.0 112.04 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.09 -42.97 91.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 112.482 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.53 79.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.171 0.589 . . . . 0.0 111.493 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.94 -41.89 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.154 0.582 . . . . 0.0 112.112 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.32 -44.21 95.66 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 t -63.88 -51.5 64.26 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.755 0.822 . . . . 0.0 111.791 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.8 tt -63.45 -30.85 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.292 -0.88 . . . . 0.0 112.643 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -40.86 97.89 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.411 1.084 . . . . 0.0 112.036 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 125.066 1.346 . . . . 0.0 113.723 174.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -51.54 -39.77 58.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.205 1.802 . . . . 0.0 113.742 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.04 -31.53 71.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.414 1.086 . . . . 0.0 112.474 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -66.01 -50.77 63.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.497 0.665 . . . . 0.0 110.486 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.7 mt -62.07 -35.86 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.578 1.551 . . . . 0.0 110.851 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -56.35 -39.47 72.9 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.711 1.204 . . . . 0.0 112.516 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.9 mt -68.92 -53.85 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.377 1.071 . . . . 0.0 110.597 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.96 -29.6 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.392 0.677 . . . . 0.0 112.727 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.09 67.6 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.849 1.214 . . . . 0.0 114.284 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.54 -52.06 37.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.708 1.254 . . . . 0.0 111.849 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 125.498 1.519 . . . . 0.0 112.9 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.49 -42.2 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.527 1.131 . . . . 0.0 111.869 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.52 -44.14 97.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.716 1.606 . . . . 0.0 112.692 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -45.58 88.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.131 0.573 . . . . 0.0 111.612 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.47 -40.48 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.373 1.069 . . . . 0.0 111.8 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.34 -43.45 98.79 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.668 -1.27 . . . . 0.0 112.481 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.5 m -63.94 -51.16 65.72 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.188 0.995 . . . . 0.0 112.16 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.48 -31.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.845 0.748 . . . . 0.0 112.43 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.26 -40.43 95.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.438 1.017 . . . . 0.0 112.505 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptt . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 175.193 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -57.13 -44.79 83.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.308 1.043 . . . . 0.0 112.112 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -44.77 95.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.683 1.193 . . . . 0.0 111.696 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.57 -51.53 69.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.271 0.487 . . . . 0.0 111.761 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.93 -39.82 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.875 1.27 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.81 -47.55 85.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.238 0.926 . . . . 0.0 112.609 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.61 -53.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.0 0.92 . . . . 0.0 110.783 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.8 m -66.36 -38.68 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.144 0.578 . . . . 0.0 112.255 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.83 -32.59 84.69 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.336 1.446 . . . . 0.0 113.38 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.21 -53.27 41.02 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.374 1.087 . . . . 0.0 112.078 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.983 1.313 . . . . 0.0 113.159 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -56.19 -40.5 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.017 0.927 . . . . 0.0 111.551 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -43.96 98.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.749 0.819 . . . . 0.0 112.613 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.76 90.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.729 0.811 . . . . 0.0 111.925 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.8 -40.64 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.966 0.906 . . . . 0.0 111.825 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.95 -42.86 99.59 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.872 -1.142 . . . . 0.0 112.041 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.0 t -63.16 -51.48 66.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.404 0.682 . . . . 0.0 112.066 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tt -66.22 -26.45 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.359 -0.838 . . . . 0.0 112.687 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -66.05 -39.58 90.23 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.92 -1.112 . . . . 0.0 112.763 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.122 0.969 . . . . 0.0 112.362 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -54.72 -44.04 73.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.465 1.106 . . . . 0.0 112.97 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.62 -45.27 91.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.483 1.113 . . . . 0.0 111.816 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.92 -50.95 71.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.031 0.532 . . . . 0.0 111.784 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.86 -40.29 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.654 1.582 . . . . 0.0 111.152 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.29 -42.0 98.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.346 0.975 . . . . 0.0 113.485 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.99 -53.84 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.02 0.827 . . . . 0.0 110.612 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.81 -30.67 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.93 -30.78 70.54 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.795 1.664 . . . . 0.0 113.762 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.81 -56.92 6.18 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.172 0.986 . . . . 0.0 110.945 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 125.788 1.635 . . . . 0.0 113.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -55.67 -44.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.458 0.703 . . . . 0.0 111.651 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -44.43 97.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.346 0.659 . . . . 0.0 112.327 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.64 91.2 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.725 0.81 . . . . 0.0 112.496 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.43 -42.43 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.701 0.8 . . . . 0.0 111.406 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -58.22 -44.41 88.17 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.15 -0.969 . . . . 0.0 112.082 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -64.55 -51.51 62.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.733 0.813 . . . . 0.0 112.547 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.1 -30.34 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.2 -0.937 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -42.04 95.37 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.647 1.179 . . . . 0.0 112.203 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 125.703 1.601 . . . . 0.0 113.621 177.112 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -58.15 -38.45 76.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.122 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.31 -42.14 72.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.071 0.948 . . . . 0.0 111.365 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.89 -51.42 69.71 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.329 0.513 . . . . 0.0 111.365 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.0 mt -55.72 -43.11 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.98 1.312 . . . . 0.0 111.211 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -58.27 -46.57 85.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.777 0.831 . . . . 0.0 112.494 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.18 -53.82 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.0 0.92 . . . . 0.0 111.106 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.37 -24.14 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.3 -22.89 51.99 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.795 1.664 . . . . 0.0 113.514 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.96 -57.96 4.62 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.417 1.108 . . . . 0.0 110.37 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 125.642 1.577 . . . . 0.0 113.744 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.2 mt . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.67 -40.12 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.143 0.977 . . . . 0.0 111.893 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.59 -45.32 94.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.207 1.003 . . . . 0.0 112.031 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.65 93.43 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 0.0 111.997 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.0 -41.25 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.168 0.987 . . . . 0.0 111.669 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.98 -41.36 97.93 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.825 -1.172 . . . . 0.0 112.427 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 m -64.85 -51.51 61.65 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.67 0.788 . . . . 0.0 112.386 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -64.7 -32.42 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.108 0.867 . . . . 0.0 112.467 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.66 -32.47 63.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.067 1.347 . . . . 0.0 113.17 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -54.8 -45.98 74.42 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.538 1.135 . . . . 0.0 112.358 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.84 -42.92 84.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.13 1.372 . . . . 0.0 112.329 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -58.15 -53.01 63.15 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.451 0.569 . . . . 0.0 111.392 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -56.06 -40.84 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.806 1.642 . . . . 0.0 110.94 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.8 mmm -57.2 -47.83 80.29 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.09 0.956 . . . . 0.0 112.335 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.02 -53.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.811 0.844 . . . . 0.0 111.284 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.12 -30.42 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.49 -19.63 71.0 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.724 1.63 . . . . 0.0 113.675 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.71 -50.16 20.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.01 1.405 . . . . 0.0 110.559 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 126.024 1.73 . . . . 0.0 112.803 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -56.78 -40.81 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.371 1.468 . . . . 0.0 111.672 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.99 -43.8 98.34 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.984 0.914 . . . . 0.0 112.332 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.08 92.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.5 -40.37 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.003 0.921 . . . . 0.0 111.824 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.6 mt -62.91 -43.54 98.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.011 -1.056 . . . . 0.0 111.607 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -64.4 -49.06 73.05 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.568 0.747 . . . . 0.0 112.173 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.24 -34.21 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.8 0.727 . . . . 0.0 112.583 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.41 -31.45 65.85 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.305 1.442 . . . . 0.0 113.939 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 125.162 1.385 . . . . 0.0 113.655 176.228 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -55.31 -50.21 70.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.202 1.401 . . . . 0.0 112.792 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.63 -43.52 98.71 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 111.336 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -56.31 -47.73 78.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.714 0.688 . . . . 0.0 111.903 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.05 -40.25 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 111.312 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 mtp -64.67 -41.12 96.3 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.251 -0.906 . . . . 0.0 113.186 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -62.12 -53.66 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.247 1.019 . . . . 0.0 110.768 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.81 -29.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.82 93.48 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.683 1.135 . . . . 0.0 112.9 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.55 89.85 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.078 0.939 . . . . 0.0 112.149 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.315 1.446 . . . . 0.0 112.89 175.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -58.14 -42.11 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.801 0.84 . . . . 0.0 111.627 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -44.63 93.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.001 0.92 . . . . 0.0 112.28 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -36.62 80.57 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.862 0.865 . . . . 0.0 112.689 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.34 -40.02 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.115 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.31 -44.86 95.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.877 -1.139 . . . . 0.0 112.418 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -66.08 -47.6 73.71 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.771 0.714 . . . . 0.0 112.827 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.18 -33.07 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.356 0.98 . . . . 0.0 112.453 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -62.37 -39.01 91.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.004 0.922 . . . . 0.0 111.856 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 124.715 1.206 . . . . 0.0 113.157 177.618 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -55.22 -42.94 74.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.838 1.255 . . . . 0.0 112.997 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.61 -42.69 91.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 111.55 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -60.22 -49.15 78.75 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.678 0.791 . . . . 0.0 112.14 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -55.01 -45.0 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.265 1.426 . . . . 0.0 111.03 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.5 mmm -56.56 -42.93 79.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.194 0.998 . . . . 0.0 112.905 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.68 -53.8 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.05 0.94 . . . . 0.0 111.252 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.27 -26.98 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.82 -30.41 66.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.43 1.014 . . . . 0.0 113.471 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.81 -51.65 33.86 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.308 1.054 . . . . 0.0 111.737 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.884 1.673 . . . . 0.0 112.793 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -58.56 -41.46 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.748 0.819 . . . . 0.0 112.08 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.53 -42.43 96.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.73 1.212 . . . . 0.0 112.649 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.96 92.15 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.628 0.771 . . . . 0.0 111.875 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.33 -40.05 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.104 0.962 . . . . 0.0 111.716 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mt -60.85 -44.83 96.46 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.45 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 t -62.99 -51.58 66.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.915 0.886 . . . . 0.0 112.096 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -63.41 -33.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.319 -0.863 . . . . 0.0 112.518 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -61.98 -27.95 69.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.226 1.011 . . . . 0.0 113.036 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -50.73 -43.37 58.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.238 1.815 . . . . 0.0 112.469 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 31.6 mt -69.47 -42.51 74.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.16 1.384 . . . . 0.0 111.544 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -56.54 -47.64 79.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.299 0.64 . . . . 0.0 111.605 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.6 mt -54.45 -43.22 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.807 1.243 . . . . 0.0 111.339 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtm -60.84 -46.37 90.81 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.428 -0.795 . . . . 0.0 112.502 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.13 -53.68 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.308 1.043 . . . . 0.0 110.963 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 m -65.4 -29.8 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.74 87.38 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.869 1.224 . . . . 0.0 113.802 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.63 -46.5 93.6 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 118.323 1.061 . . . . 0.0 112.667 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.803 1.641 . . . . 0.0 112.722 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.7 -49.28 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.096 0.958 . . . . 0.0 111.52 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.55 -44.82 93.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.676 0.79 . . . . 0.0 112.813 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.13 83.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.455 0.702 . . . . 0.0 112.614 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.85 -41.89 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.265 1.026 . . . . 0.0 111.413 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.1 -43.2 95.72 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.874 -1.141 . . . . 0.0 112.275 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m -63.39 -51.41 65.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.476 0.711 . . . . 0.0 112.851 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.1 tt -64.72 -33.05 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.242 0.928 . . . . 0.0 112.859 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -61.07 -42.48 98.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 0.0 112.178 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 125.639 1.575 . . . . 0.0 114.828 176.254 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -57.2 -46.16 83.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.122 0.969 . . . . 0.0 112.907 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.15 -42.79 95.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.516 1.126 . . . . 0.0 112.113 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -58.31 -49.93 75.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.647 0.658 . . . . 0.0 111.647 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.38 -40.01 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.572 1.149 . . . . 0.0 111.527 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.5 mmt -59.33 -42.17 90.84 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.479 1.036 . . . . 0.0 112.843 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.29 -53.57 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.389 0.676 . . . . 0.0 111.013 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.21 -35.42 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.57 82.83 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.564 1.554 . . . . 0.0 112.616 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.28 58.22 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 125.926 1.691 . . . . 0.0 113.635 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.16 -41.97 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.892 1.277 . . . . 0.0 111.666 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -45.05 95.3 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.773 1.229 . . . . 0.0 112.344 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.05 -45.69 90.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.421 0.688 . . . . 0.0 112.055 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.75 -42.6 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.73 1.212 . . . . 0.0 111.393 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.3 -43.84 95.93 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.91 -1.119 . . . . 0.0 111.788 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.5 m -64.05 -50.77 67.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 112.681 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.73 -30.86 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.044 0.838 . . . . 0.0 112.614 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -61.14 -43.19 99.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.562 1.145 . . . . 0.0 111.636 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 0.0 113.924 177.729 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -56.5 -45.79 80.86 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.937 1.295 . . . . 0.0 112.241 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.81 -43.47 96.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.788 1.235 . . . . 0.0 111.569 175.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -57.42 -49.8 75.05 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.578 -0.701 . . . . 0.0 111.775 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mt -58.38 -39.12 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.894 1.278 . . . . 0.0 111.056 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmm -61.3 -43.59 98.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.663 0.785 . . . . 0.0 112.291 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.85 -53.58 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.794 0.838 . . . . 0.0 111.07 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.8 -38.21 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.979 0.511 . . . . 0.0 112.231 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.38 91.37 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.43 1.49 . . . . 0.0 112.915 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -47.87 84.98 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.179 0.99 . . . . 0.0 111.862 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 124.328 1.051 . . . . 0.0 113.093 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.65 -42.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.146 0.978 . . . . 0.0 111.848 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.37 -40.93 96.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.818 0.847 . . . . 0.0 112.296 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.37 97.43 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.802 -0.561 . . . . 0.0 111.221 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.71 -40.33 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.518 0.727 . . . . 0.0 112.16 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.45 -41.95 99.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.955 -1.091 . . . . 0.0 112.183 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t -67.1 -50.46 61.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 0.0 112.38 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.44 -33.32 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.099 -1.0 . . . . 0.0 112.54 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -58.34 -34.12 70.29 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.649 1.18 . . . . 0.0 113.729 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm . . . . . 0 N--CA 1.476 0.851 0 C-N-CA 125.271 1.428 . . . . 0.0 113.688 175.147 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -55.95 -45.56 78.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.86 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.93 -44.56 96.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.934 0.894 . . . . 0.0 111.931 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.26 -51.01 71.08 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.198 0.454 . . . . 0.0 111.611 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.86 -40.52 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.723 1.209 . . . . 0.0 111.116 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmt -60.8 -46.13 91.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.028 0.831 . . . . 0.0 112.519 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.16 -53.69 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.899 0.879 . . . . 0.0 111.155 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.17 -29.19 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.26 -31.85 78.59 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.482 1.515 . . . . 0.0 113.277 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.18 -43.41 80.49 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.408 1.104 . . . . 0.0 111.955 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.769 -0.085 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.16 -43.15 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.636 0.774 . . . . 0.0 111.558 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.94 -41.01 95.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.301 1.04 . . . . 0.0 111.956 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.66 79.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.447 0.699 . . . . 0.0 111.709 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.5 -41.35 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 111.613 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.09 -42.51 98.64 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.963 -1.086 . . . . 0.0 112.707 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 m -66.67 -51.42 56.26 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.579 0.752 . . . . 0.0 112.274 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.82 -33.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 119.48 1.036 . . . . 0.0 112.519 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -56.58 -34.03 66.76 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.115 0.966 . . . . 0.0 112.648 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -56.61 -47.16 80.23 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.337 1.055 . . . . 0.0 112.575 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.16 -42.35 94.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.573 1.149 . . . . 0.0 111.979 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.2 -48.77 77.96 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.472 0.578 . . . . 0.0 111.412 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.73 -38.99 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.075 1.35 . . . . 0.0 111.266 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.4 mtt -59.81 -41.54 91.48 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.389 0.995 . . . . 0.0 112.39 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.97 -53.78 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.13 0.972 . . . . 0.0 110.69 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.69 -26.22 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.0 -27.72 62.69 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.543 1.544 . . . . 0.0 113.97 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 -52.61 30.15 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 118.469 1.134 . . . . 0.0 111.187 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.399 1.479 . . . . 0.0 113.369 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.77 -41.94 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.36 1.064 . . . . 0.0 111.901 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -45.96 92.04 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.756 0.822 . . . . 0.0 112.356 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 -44.18 94.11 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.796 0.838 . . . . 0.0 112.274 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.72 -41.59 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.285 1.034 . . . . 0.0 111.486 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.64 -42.07 98.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.974 -1.079 . . . . 0.0 112.217 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.7 m -64.7 -49.29 71.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.778 0.831 . . . . 0.0 112.584 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.05 -30.79 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.219 0.918 . . . . 0.0 112.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -60.71 -28.04 68.35 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.388 1.075 . . . . 0.0 113.844 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt . . . . . 0 N--CA 1.478 0.945 0 C-N-CA 125.29 1.436 . . . . 0.0 113.639 175.038 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -56.78 -37.23 70.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.161 1.384 . . . . 0.0 112.906 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.62 -45.21 72.49 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.104 1.362 . . . . 0.0 111.448 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.38 -52.2 66.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.126 0.57 . . . . 0.0 111.889 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -39.85 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.282 1.433 . . . . 0.0 110.795 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 mmm -59.73 -51.39 69.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.915 . . . . 0.0 111.977 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.84 -51.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.595 0.758 . . . . 0.0 111.368 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 m -67.85 -37.55 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.157 0.583 . . . . 0.0 111.977 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.77 99.52 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.545 1.545 . . . . 0.0 112.811 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.17 -45.82 93.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 117.949 0.874 . . . . 0.0 111.913 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.903 1.281 . . . . 0.0 112.871 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.63 -44.91 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.963 0.905 . . . . 0.0 111.722 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.8 -37.82 85.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.983 0.913 . . . . 0.0 112.478 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.28 86.12 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.545 0.611 . . . . 0.0 111.471 174.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.38 -41.81 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.287 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.54 -42.28 96.22 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.891 -1.131 . . . . 0.0 112.544 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -66.87 -49.51 65.42 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.292 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.6 tt -63.32 -35.75 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.583 1.083 . . . . 0.0 112.454 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -35.74 69.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.554 1.141 . . . . 0.0 111.996 174.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.7 tttt . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 126.108 1.763 . . . . 0.0 114.253 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -53.01 -44.73 67.5 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.577 1.551 . . . . 0.0 111.718 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.96 -45.21 86.66 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.791 1.236 . . . . 0.0 111.432 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.11 -52.85 63.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 111.244 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.38 -42.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.977 1.311 . . . . 0.0 111.151 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -46.45 80.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.237 1.015 . . . . 0.0 112.475 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.05 -53.9 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.23 1.012 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.1 -27.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.93 -25.52 64.18 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.735 1.636 . . . . 0.0 113.819 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.02 -54.04 15.93 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.636 1.218 . . . . 0.0 110.589 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.636 1.574 . . . . 0.0 113.287 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.7 -40.01 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.758 -0.589 . . . . 0.0 112.023 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -42.24 92.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.264 1.026 . . . . 0.0 112.333 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.96 87.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.726 0.81 . . . . 0.0 111.854 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.7 -41.96 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 111.901 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.7 -40.59 95.58 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.017 -1.052 . . . . 0.0 112.385 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -66.62 -51.53 55.27 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.762 0.825 . . . . 0.0 112.101 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 tt -63.72 -32.43 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.391 -0.818 . . . . 0.0 112.61 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -56.97 -36.79 70.73 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.394 1.477 . . . . 0.0 113.372 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 C-N-CA 125.224 1.41 . . . . 0.0 113.556 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -54.31 -38.73 66.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.959 1.304 . . . . 0.0 113.676 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.17 -39.61 71.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.279 1.032 . . . . 0.0 111.951 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.18 -48.83 79.09 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.426 0.557 . . . . 0.0 111.463 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.5 mt -57.94 -39.71 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.004 1.321 . . . . 0.0 110.978 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.03 -38.3 88.18 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.27 -0.894 . . . . 0.0 113.395 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.9 mt -65.31 -53.86 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.009 0.924 . . . . 0.0 110.459 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.33 -22.07 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.56 -26.22 59.42 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.869 1.7 . . . . 0.0 114.402 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.9 8.66 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.673 1.236 . . . . 0.0 111.232 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 125.765 1.626 . . . . 0.0 113.381 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.32 -43.12 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.922 1.289 . . . . 0.0 111.752 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.32 -42.65 99.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.303 1.041 . . . . 0.0 112.353 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.1 97.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.525 -0.734 . . . . 0.0 111.715 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.07 -35.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.588 1.155 . . . . 0.0 111.716 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.0 -45.23 78.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.673 -1.267 . . . . 0.0 110.754 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 m -62.72 -47.43 83.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.386 1.074 . . . . 0.0 112.472 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 tt -66.82 -35.75 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 118.962 0.801 . . . . 0.0 112.571 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -59.87 -24.48 64.28 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.087 1.312 . . . . 0.0 113.461 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.99 175.374 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 pttm . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -59.04 -35.53 73.47 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 0.0 113.704 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -54.78 -46.32 74.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.698 1.599 . . . . 0.0 112.968 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.76 -45.12 91.24 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.932 0.893 . . . . 0.0 111.87 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.06 -50.08 74.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.385 0.539 . . . . 0.0 111.763 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -58.08 -37.32 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.213 1.405 . . . . 0.0 110.852 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.6 mtt -61.95 -44.32 97.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.83 1.196 . . . . 0.0 112.228 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.46 -53.71 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.025 0.93 . . . . 0.0 110.729 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.38 -27.98 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.23 -40.61 99.25 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.532 1.539 . . . . 0.0 112.989 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.16 94.35 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 118.04 0.92 . . . . 0.0 112.256 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -57.28 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.552 1.541 . . . . 0.0 112.233 174.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.17 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.466 1.106 . . . . 0.0 111.492 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.66 27.57 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.647 1.594 . . . . 0.0 114.522 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -35.71 65.81 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.734 1.267 . . . . 0.0 111.686 175.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -58.17 -46.04 86.44 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.223 1.009 . . . . 0.0 112.008 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 62.1 mt -70.35 -48.67 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.234 1.414 . . . . 0.0 109.98 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.75 -44.58 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.055 0.942 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.5 -45.79 92.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.495 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.4 81.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.363 0.665 . . . . 0.0 112.104 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.18 -39.97 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.072 0.949 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.24 -42.64 99.24 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.798 -1.189 . . . . 0.0 111.992 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -63.26 -51.53 65.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 112.193 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -64.41 -31.63 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.308 -0.87 . . . . 0.0 112.653 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -34.85 76.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.827 1.251 . . . . 0.0 112.561 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -26.66 62.23 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.259 1.024 . . . . 0.0 112.659 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.946 1.698 . . . . 0.0 113.477 179.054 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -60.91 -46.57 90.11 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 121.219 1.827 . . . . 0.0 113.826 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -52.66 -41.32 63.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.929 1.291 . . . . 0.0 113.003 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.83 -47.7 65.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.111 1.764 . . . . 0.0 111.651 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.79 -49.33 76.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.388 0.54 . . . . 0.0 111.96 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.37 -37.11 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 111.167 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -43.33 97.5 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.426 1.012 . . . . 0.0 112.801 175.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.85 -53.67 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.481 0.712 . . . . 0.0 110.846 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.99 -34.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.018 0.527 . . . . 0.0 112.4 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.53 77.48 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.426 1.489 . . . . 0.0 113.838 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.85 -56.59 12.16 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.058 0.929 . . . . 0.0 111.6 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -51.63 69.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.397 1.479 . . . . 0.0 113.629 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.68 -38.65 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.123 1.369 . . . . 0.0 111.326 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.41 92.9 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.078 0.847 . . . . 0.0 113.029 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -37.51 68.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.538 1.135 . . . . 0.0 113.084 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -58.61 -41.52 86.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.255 1.022 . . . . 0.0 112.372 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.68 -48.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.52 1.128 . . . . 0.0 109.952 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -57.44 -40.35 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.858 0.863 . . . . 0.0 111.954 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -43.24 91.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.137 0.975 . . . . 0.0 112.277 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.56 84.86 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.794 0.838 . . . . 0.0 111.591 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.97 -41.16 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.83 -43.43 94.58 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.905 -1.122 . . . . 0.0 112.007 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 t -67.32 -48.14 68.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.589 0.756 . . . . 0.0 112.394 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.9 tt -64.15 -31.86 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.372 -0.83 . . . . 0.0 112.453 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -61.49 -40.51 94.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.27 0.941 . . . . 0.0 112.531 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -68.43 -22.28 64.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.452 1.101 . . . . 0.0 112.541 179.582 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.629 0.252 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -64.57 -37.96 89.36 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.966 0.906 . . . . 0.0 112.861 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -53.98 -42.95 69.55 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.572 1.549 . . . . 0.0 113.056 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.58 -47.93 83.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.287 1.035 . . . . 0.0 112.156 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.09 -51.75 68.7 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.915 -0.491 . . . . 0.0 111.65 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -54.86 -39.51 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.547 1.539 . . . . 0.0 111.276 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -48.84 80.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.186 0.995 . . . . 0.0 111.989 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.3 mt -65.13 -53.82 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 110.977 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -69.28 -34.04 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.62 90.42 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.701 1.619 . . . . 0.0 112.897 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -49.32 59.82 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.273 1.037 . . . . 0.0 111.049 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -58.05 9.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.062 1.745 . . . . 0.0 113.371 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.61 -41.9 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.554 1.142 . . . . 0.0 111.228 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.94 -31.22 71.65 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.218 0.913 . . . . 0.0 113.569 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -37.58 61.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.663 1.232 . . . . 0.0 112.097 175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.3 mmm-85 -59.43 -41.16 88.94 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.061 1.344 . . . . 0.0 111.88 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.68 -50.13 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.994 1.718 . . . . 0.0 110.095 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.8 -40.58 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.738 . . . . 0.0 111.701 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -61.58 -38.32 87.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.358 1.063 . . . . 0.0 112.468 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.55 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.425 0.69 . . . . 0.0 111.349 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.1 -42.3 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.607 1.163 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.84 -39.88 95.72 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.747 -1.221 . . . . 0.0 112.302 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.27 -51.44 60.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.268 1.027 . . . . 0.0 112.136 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.8 -34.4 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.289 -0.882 . . . . 0.0 112.546 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -56.33 -31.76 64.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.978 1.311 . . . . 0.0 113.585 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -76.1 -13.64 60.2 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.807 1.243 . . . . 0.0 113.779 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 pttt . . . . . 0 C--O 1.253 1.271 0 C-N-CA 125.539 1.536 . . . . 0.0 112.964 177.484 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -51.44 -37.3 47.97 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 120.305 1.411 . . . . 0.0 114.155 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -52.69 -43.46 65.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.497 1.519 . . . . 0.0 113.032 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -64.6 -46.52 82.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 111.509 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -56.59 -50.75 71.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.999 0.519 . . . . 0.0 111.472 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.21 -42.82 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.443 1.097 . . . . 0.0 111.07 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.84 -44.81 93.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.41 1.005 . . . . 0.0 112.815 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.96 -53.78 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.857 0.863 . . . . 0.0 111.159 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.0 m -69.39 -24.78 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.64 -31.18 66.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.39 1.472 . . . . 0.0 113.54 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.25 75.79 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.391 1.095 . . . . 0.0 111.734 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -54.28 48.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.421 1.488 . . . . 0.0 112.992 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -64.88 -40.17 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 111.476 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.15 -31.79 56.51 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.836 1.207 . . . . 0.0 113.918 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.11 -40.34 70.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.511 1.156 . . . . 0.0 112.502 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -61.01 -38.69 86.98 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.94 0.791 . . . . 0.0 112.55 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.0 mt -68.4 -51.52 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.92 1.288 . . . . 0.0 109.866 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.93 -41.56 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.829 0.852 . . . . 0.0 111.78 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.89 -40.61 96.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.851 0.86 . . . . 0.0 112.685 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.83 91.75 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.734 -0.604 . . . . 0.0 111.673 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.73 -42.38 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.792 0.837 . . . . 0.0 111.962 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.01 -33.97 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.527 -1.358 . . . . 0.0 113.371 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -72.34 -50.94 23.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.095 0.958 . . . . 0.0 111.782 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.62 -31.69 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.244 -0.91 . . . . 0.0 112.951 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -58.52 -30.89 67.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.921 -1.112 . . . . 0.0 113.721 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -71.5 -21.43 61.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.254 1.331 0 CA-C-O 117.251 -1.357 . . . . 0.0 113.571 -178.477 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.1 mptt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 119.69 -0.195 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -55.6 -51.16 68.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.566 1.546 . . . . 0.0 112.717 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -52.33 -53.79 39.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.268 1.427 . . . . 0.0 111.862 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.96 -45.99 89.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.45 1.5 . . . . 0.0 112.032 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -55.25 -50.09 70.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.376 0.671 . . . . 0.0 111.504 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mt -58.16 -38.15 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.678 1.191 . . . . 0.0 111.315 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.9 mtp -64.98 -43.5 92.4 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.476 1.035 . . . . 0.0 112.643 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.26 -53.71 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.971 0.908 . . . . 0.0 110.723 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.03 -26.84 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.4 -37.0 79.45 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.567 1.556 . . . . 0.0 113.022 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.97 -51.87 55.87 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.671 0.736 . . . . 0.0 111.404 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.85 -53.45 52.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.177 1.791 . . . . 0.0 113.348 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.8 -45.01 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.68 91.76 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.23 0.919 . . . . 0.0 112.75 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -35.96 73.09 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.542 1.137 . . . . 0.0 113.145 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -57.87 -42.95 85.61 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 112.285 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.59 -50.81 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.461 1.505 . . . . 0.0 109.446 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.2 -45.23 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.303 1.041 . . . . 0.0 112.04 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.09 -42.97 91.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 112.482 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.53 79.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.171 0.589 . . . . 0.0 111.493 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.94 -41.89 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.154 0.582 . . . . 0.0 112.112 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.32 -44.21 95.66 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 t -63.88 -51.5 64.26 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.755 0.822 . . . . 0.0 111.791 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.8 tt -63.45 -30.85 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.292 -0.88 . . . . 0.0 112.643 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -40.86 97.89 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.411 1.084 . . . . 0.0 112.036 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -71.02 -22.87 62.1 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.066 1.346 . . . . 0.0 113.723 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 pttt . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.152 -178.233 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.9 tttt . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -46.36 -37.35 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.247 2.219 . . . . 0.0 114.675 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -51.54 -39.77 58.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.205 1.802 . . . . 0.0 113.742 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.04 -31.53 71.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.414 1.086 . . . . 0.0 112.474 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -66.01 -50.77 63.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.497 0.665 . . . . 0.0 110.486 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.7 mt -62.07 -35.86 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.578 1.551 . . . . 0.0 110.851 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -56.35 -39.47 72.9 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.711 1.204 . . . . 0.0 112.516 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.9 mt -68.92 -53.85 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.377 1.071 . . . . 0.0 110.597 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.96 -29.6 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.392 0.677 . . . . 0.0 112.727 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.09 67.6 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.849 1.214 . . . . 0.0 114.284 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.54 -52.06 37.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.708 1.254 . . . . 0.0 111.849 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -52.69 64.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.498 1.519 . . . . 0.0 112.9 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.45 -41.54 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.697 1.199 . . . . 0.0 111.609 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.46 -44.21 95.46 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.366 0.984 . . . . 0.0 112.643 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -45.72 74.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.196 0.998 . . . . 0.0 112.089 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -56.56 -45.57 81.21 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.579 1.152 . . . . 0.0 112.984 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -64.44 -51.14 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.553 1.141 . . . . 0.0 109.63 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.49 -42.2 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.527 1.131 . . . . 0.0 111.869 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.52 -44.14 97.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.716 1.606 . . . . 0.0 112.692 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -45.58 88.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.131 0.573 . . . . 0.0 111.612 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.47 -40.48 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.373 1.069 . . . . 0.0 111.8 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.34 -43.45 98.79 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.668 -1.27 . . . . 0.0 112.481 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.5 m -63.94 -51.16 65.72 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.188 0.995 . . . . 0.0 112.16 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.48 -31.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.845 0.748 . . . . 0.0 112.43 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.26 -40.43 95.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.438 1.017 . . . . 0.0 112.505 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.78 -14.71 60.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.485 1.293 0 C-N-CA 126.522 1.929 . . . . 0.0 113.221 -179.418 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.018 -0.039 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -60.42 -37.64 81.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.213 1.005 . . . . 0.0 113.215 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -57.13 -44.79 83.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.308 1.043 . . . . 0.0 112.112 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -44.77 95.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.683 1.193 . . . . 0.0 111.696 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.57 -51.53 69.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.271 0.487 . . . . 0.0 111.761 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.93 -39.82 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.875 1.27 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.81 -47.55 85.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.238 0.926 . . . . 0.0 112.609 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.61 -53.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.0 0.92 . . . . 0.0 110.783 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.8 m -66.36 -38.68 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.144 0.578 . . . . 0.0 112.255 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.83 -32.59 84.69 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.336 1.446 . . . . 0.0 113.38 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.21 -53.27 41.02 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.374 1.087 . . . . 0.0 112.078 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.45 46.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.983 1.313 . . . . 0.0 113.159 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.6 -32.96 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.11 0.964 . . . . 0.0 111.677 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.38 -40.74 23.51 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.935 1.731 . . . . 0.0 113.537 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -39.5 79.38 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.133 0.973 . . . . 0.0 112.483 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -62.94 -40.31 97.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.279 1.032 . . . . 0.0 112.21 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.85 -45.31 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.921 1.288 . . . . 0.0 110.228 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -56.19 -40.5 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.017 0.927 . . . . 0.0 111.551 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -43.96 98.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.749 0.819 . . . . 0.0 112.613 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.76 90.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.729 0.811 . . . . 0.0 111.925 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.8 -40.64 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.966 0.906 . . . . 0.0 111.825 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.95 -42.86 99.59 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.872 -1.142 . . . . 0.0 112.041 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.0 t -63.16 -51.48 66.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.404 0.682 . . . . 0.0 112.066 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tt -66.22 -26.45 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.359 -0.838 . . . . 0.0 112.687 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -66.05 -39.58 90.23 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.92 -1.112 . . . . 0.0 112.763 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.88 -28.46 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.122 0.969 . . . . 0.0 112.362 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 pttt . . . . . 0 C--O 1.253 1.279 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.178 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.6 mttp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.675 -0.203 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -59.71 -33.66 71.9 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -54.72 -44.04 73.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.465 1.106 . . . . 0.0 112.97 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.62 -45.27 91.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.483 1.113 . . . . 0.0 111.816 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.92 -50.95 71.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.031 0.532 . . . . 0.0 111.784 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.86 -40.29 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.654 1.582 . . . . 0.0 111.152 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.29 -42.0 98.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.346 0.975 . . . . 0.0 113.485 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.99 -53.84 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.02 0.827 . . . . 0.0 110.612 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.81 -30.67 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.93 -30.78 70.54 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.795 1.664 . . . . 0.0 113.762 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.81 -56.92 6.18 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.172 0.986 . . . . 0.0 110.945 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -56.33 23.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.788 1.635 . . . . 0.0 113.478 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.1 -41.94 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.105 1.362 . . . . 0.0 110.776 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.09 62.74 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.4 1.0 . . . . 0.0 112.727 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -42.81 68.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.56 1.144 . . . . 0.0 112.998 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -40.52 97.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.148 0.979 . . . . 0.0 112.131 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.15 -48.01 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.198 0.999 . . . . 0.0 109.838 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -55.67 -44.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.458 0.703 . . . . 0.0 111.651 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -44.43 97.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.346 0.659 . . . . 0.0 112.327 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.64 91.2 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.725 0.81 . . . . 0.0 112.496 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.43 -42.43 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.701 0.8 . . . . 0.0 111.406 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -58.22 -44.41 88.17 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.15 -0.969 . . . . 0.0 112.082 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -64.55 -51.51 62.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.733 0.813 . . . . 0.0 112.547 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.1 -30.34 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.2 -0.937 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -42.04 95.37 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.647 1.179 . . . . 0.0 112.203 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -72.05 -21.36 61.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.703 1.601 . . . . 0.0 113.621 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.574 1.95 . . . . 0.0 113.434 -169.354 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.9 mttt . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -40.73 11.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.583 1.953 . . . . 0.0 115.111 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -58.15 -38.45 76.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.122 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.31 -42.14 72.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.071 0.948 . . . . 0.0 111.365 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.89 -51.42 69.71 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.329 0.513 . . . . 0.0 111.365 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.0 mt -55.72 -43.11 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.98 1.312 . . . . 0.0 111.211 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -58.27 -46.57 85.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.777 0.831 . . . . 0.0 112.494 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.18 -53.82 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.0 0.92 . . . . 0.0 111.106 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.37 -24.14 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.3 -22.89 51.99 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.795 1.664 . . . . 0.0 113.514 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.96 -57.96 4.62 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.417 1.108 . . . . 0.0 110.37 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -54.0 34.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.642 1.577 . . . . 0.0 113.744 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.35 -49.7 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.091 1.356 . . . . 0.0 110.836 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.79 -24.39 53.44 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.8 0.714 . . . . 0.0 113.989 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -31.86 62.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.43 1.092 . . . . 0.0 111.638 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -57.51 -35.9 70.86 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.4 1.0 . . . . 0.0 113.355 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.21 -49.22 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.699 1.6 . . . . 0.0 109.383 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.67 -40.12 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.143 0.977 . . . . 0.0 111.893 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.59 -45.32 94.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.207 1.003 . . . . 0.0 112.031 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.65 93.43 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 0.0 111.997 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.0 -41.25 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.168 0.987 . . . . 0.0 111.669 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.98 -41.36 97.93 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.825 -1.172 . . . . 0.0 112.427 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 m -64.85 -51.51 61.65 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.67 0.788 . . . . 0.0 112.386 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -64.7 -32.42 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.108 0.867 . . . . 0.0 112.467 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.66 -32.47 63.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.067 1.347 . . . . 0.0 113.17 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -13.72 60.41 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.028 1.731 . . . . 0.0 112.1 -177.662 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.159 0.028 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -60.59 -43.0 97.87 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 0.0 112.747 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -54.8 -45.98 74.42 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.538 1.135 . . . . 0.0 112.358 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.84 -42.92 84.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.13 1.372 . . . . 0.0 112.329 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -58.15 -53.01 63.15 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.451 0.569 . . . . 0.0 111.392 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -56.06 -40.84 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.806 1.642 . . . . 0.0 110.94 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.8 mmm -57.2 -47.83 80.29 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.09 0.956 . . . . 0.0 112.335 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.02 -53.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.811 0.844 . . . . 0.0 111.284 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.12 -30.42 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.49 -19.63 71.0 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.724 1.63 . . . . 0.0 113.675 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.71 -50.16 20.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.01 1.405 . . . . 0.0 110.559 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -57.79 11.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.024 1.73 . . . . 0.0 112.803 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.23 -32.99 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.64 0.776 . . . . 0.0 111.438 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.24 -34.16 53.2 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.44 1.495 . . . . 0.0 113.949 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -42.1 70.96 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.064 1.432 . . . . 0.0 111.946 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -62.02 -39.13 91.24 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.739 1.216 . . . . 0.0 112.049 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.39 -51.95 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.444 1.497 . . . . 0.0 110.34 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -56.78 -40.81 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.371 1.468 . . . . 0.0 111.672 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.99 -43.8 98.34 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.984 0.914 . . . . 0.0 112.332 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.08 92.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.5 -40.37 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.003 0.921 . . . . 0.0 111.824 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.6 mt -62.91 -43.54 98.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.011 -1.056 . . . . 0.0 111.607 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -64.4 -49.06 73.05 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.568 0.747 . . . . 0.0 112.173 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.24 -34.21 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.8 0.727 . . . . 0.0 112.583 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.41 -31.45 65.85 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.305 1.442 . . . . 0.0 113.939 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -77.03 -10.8 59.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.162 1.385 . . . . 0.0 113.655 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.565 1.546 . . . . 0.0 113.07 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -47.32 -48.77 25.1 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.083 1.753 . . . . 0.0 113.377 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -55.31 -50.21 70.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.202 1.401 . . . . 0.0 112.792 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.63 -43.52 98.71 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 111.336 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -56.31 -47.73 78.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.714 0.688 . . . . 0.0 111.903 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.05 -40.25 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 111.312 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 mtp -64.67 -41.12 96.3 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.251 -0.906 . . . . 0.0 113.186 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -62.12 -53.66 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.247 1.019 . . . . 0.0 110.768 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.81 -29.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.82 93.48 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.683 1.135 . . . . 0.0 112.9 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.55 89.85 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.078 0.939 . . . . 0.0 112.149 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -55.61 32.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.315 1.446 . . . . 0.0 112.89 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.3 -38.25 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.672 0.789 . . . . 0.0 111.576 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.15 -23.47 12.34 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.585 1.564 . . . . 0.0 115.052 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -35.17 64.25 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.639 1.22 . . . . 0.0 111.713 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -36.55 74.57 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.562 1.073 . . . . 0.0 113.252 175.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.29 -50.2 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.282 1.433 . . . . 0.0 109.188 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -58.14 -42.11 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.801 0.84 . . . . 0.0 111.627 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -44.63 93.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.001 0.92 . . . . 0.0 112.28 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -36.62 80.57 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.862 0.865 . . . . 0.0 112.689 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.34 -40.02 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.115 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.31 -44.86 95.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.877 -1.139 . . . . 0.0 112.418 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -66.08 -47.6 73.71 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.771 0.714 . . . . 0.0 112.827 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.18 -33.07 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.356 0.98 . . . . 0.0 112.453 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -62.37 -39.01 91.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.004 0.922 . . . . 0.0 111.856 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -74.71 -19.64 60.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.715 1.206 . . . . 0.0 113.157 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.251 1.42 . . . . 0.0 112.077 172.592 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -60.51 -37.14 80.18 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 119.683 -1.886 . . . . 0.0 113.506 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -55.22 -42.94 74.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.838 1.255 . . . . 0.0 112.997 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.61 -42.69 91.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 111.55 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -60.22 -49.15 78.75 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.678 0.791 . . . . 0.0 112.14 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -55.01 -45.0 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.265 1.426 . . . . 0.0 111.03 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.5 mmm -56.56 -42.93 79.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.194 0.998 . . . . 0.0 112.905 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.68 -53.8 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.05 0.94 . . . . 0.0 111.252 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.27 -26.98 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.82 -30.41 66.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.43 1.014 . . . . 0.0 113.471 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.81 -51.65 33.86 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.308 1.054 . . . . 0.0 111.737 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.48 -55.28 30.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.884 1.673 . . . . 0.0 112.793 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.08 -38.66 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.238 1.015 . . . . 0.0 111.578 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.94 -44.53 96.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.156 0.884 . . . . 0.0 112.971 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -37.02 71.38 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.13 0.972 . . . . 0.0 112.272 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -57.23 -40.95 78.6 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.436 1.095 . . . . 0.0 112.476 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.54 -51.95 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.234 1.414 . . . . 0.0 109.809 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -58.56 -41.46 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.748 0.819 . . . . 0.0 112.08 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.53 -42.43 96.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.73 1.212 . . . . 0.0 112.649 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.96 92.15 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.628 0.771 . . . . 0.0 111.875 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.33 -40.05 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.104 0.962 . . . . 0.0 111.716 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mt -60.85 -44.83 96.46 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.45 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 t -62.99 -51.58 66.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.915 0.886 . . . . 0.0 112.096 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -63.41 -33.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.319 -0.863 . . . . 0.0 112.518 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -61.98 -27.95 69.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.226 1.011 . . . . 0.0 113.036 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -14.36 50.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.576 1.55 . . . . 0.0 112.129 -177.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.336 -0.84 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -50.33 -33.41 20.16 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.435 1.471 . . . . 0.0 114.268 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -50.73 -43.37 58.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.238 1.815 . . . . 0.0 112.469 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 31.6 mt -69.47 -42.51 74.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.16 1.384 . . . . 0.0 111.544 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -56.54 -47.64 79.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.299 0.64 . . . . 0.0 111.605 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.6 mt -54.45 -43.22 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.807 1.243 . . . . 0.0 111.339 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtm -60.84 -46.37 90.81 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.428 -0.795 . . . . 0.0 112.502 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.13 -53.68 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.308 1.043 . . . . 0.0 110.963 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 m -65.4 -29.8 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.74 87.38 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.869 1.224 . . . . 0.0 113.802 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.63 -46.5 93.6 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 118.323 1.061 . . . . 0.0 112.667 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -54.64 41.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.803 1.641 . . . . 0.0 112.722 175.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.81 -36.74 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 111.421 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.14 52.59 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 112.905 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -40.51 82.92 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.888 0.844 . . . . 0.0 111.864 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -46.41 76.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.221 1.409 . . . . 0.0 112.025 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -66.68 -49.57 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.991 1.317 . . . . 0.0 109.887 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.7 -49.28 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.096 0.958 . . . . 0.0 111.52 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.55 -44.82 93.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.676 0.79 . . . . 0.0 112.813 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.13 83.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.455 0.702 . . . . 0.0 112.614 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.85 -41.89 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.265 1.026 . . . . 0.0 111.413 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.1 -43.2 95.72 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.874 -1.141 . . . . 0.0 112.275 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m -63.39 -51.41 65.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.476 0.711 . . . . 0.0 112.851 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.1 tt -64.72 -33.05 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.242 0.928 . . . . 0.0 112.859 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -61.07 -42.48 98.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 0.0 112.178 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -74.35 -15.22 60.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.639 1.575 . . . . 0.0 114.828 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 126.679 1.992 . . . . 0.0 113.181 -173.546 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -55.44 -49.12 73.27 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.224 1.81 . . . . 0.0 113.2 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -57.2 -46.16 83.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.122 0.969 . . . . 0.0 112.907 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.15 -42.79 95.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.516 1.126 . . . . 0.0 112.113 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -58.31 -49.93 75.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.647 0.658 . . . . 0.0 111.647 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.38 -40.01 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.572 1.149 . . . . 0.0 111.527 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.5 mmt -59.33 -42.17 90.84 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.479 1.036 . . . . 0.0 112.843 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.29 -53.57 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.389 0.676 . . . . 0.0 111.013 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.21 -35.42 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.57 82.83 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.564 1.554 . . . . 0.0 112.616 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.28 58.22 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -54.19 47.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.926 1.691 . . . . 0.0 113.635 176.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.12 -44.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.436 0.694 . . . . 0.0 111.245 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.45 -35.46 85.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.604 1.097 . . . . 0.0 113.491 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -41.01 68.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.973 1.309 . . . . 0.0 112.22 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.56 1.144 . . . . 0.0 111.904 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.48 -51.59 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.92 1.688 . . . . 0.0 110.122 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.16 -41.97 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.892 1.277 . . . . 0.0 111.666 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -45.05 95.3 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.773 1.229 . . . . 0.0 112.344 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.05 -45.69 90.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.421 0.688 . . . . 0.0 112.055 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.75 -42.6 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.73 1.212 . . . . 0.0 111.393 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.3 -43.84 95.93 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.91 -1.119 . . . . 0.0 111.788 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.5 m -64.05 -50.77 67.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 112.681 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.73 -30.86 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.044 0.838 . . . . 0.0 112.614 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -61.14 -43.19 99.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.562 1.145 . . . . 0.0 111.636 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -73.8 -17.61 61.06 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 0.0 113.924 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.795 2.038 . . . . 0.0 112.885 -177.308 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.266 0.079 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.75 -47.46 84.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.945 1.298 . . . . 0.0 112.794 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -56.5 -45.79 80.86 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.937 1.295 . . . . 0.0 112.241 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.81 -43.47 96.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.788 1.235 . . . . 0.0 111.569 175.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -57.42 -49.8 75.05 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.578 -0.701 . . . . 0.0 111.775 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mt -58.38 -39.12 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.894 1.278 . . . . 0.0 111.056 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmm -61.3 -43.59 98.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.663 0.785 . . . . 0.0 112.291 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.85 -53.58 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.794 0.838 . . . . 0.0 111.07 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.8 -38.21 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.979 0.511 . . . . 0.0 112.231 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.38 91.37 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.43 1.49 . . . . 0.0 112.915 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -47.87 84.98 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.179 0.99 . . . . 0.0 111.862 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -56.81 17.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.328 1.051 . . . . 0.0 113.093 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.25 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.855 0.862 . . . . 0.0 111.674 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.41 -26.91 57.49 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.221 1.391 . . . . 0.0 114.121 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -40.06 72.65 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.62 1.21 . . . . 0.0 111.47 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -60.0 -38.54 82.95 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.404 -0.81 . . . . 0.0 112.532 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm -68.28 -50.32 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.729 1.211 . . . . 0.0 110.133 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.65 -42.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.146 0.978 . . . . 0.0 111.848 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.37 -40.93 96.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.818 0.847 . . . . 0.0 112.296 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.37 97.43 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.802 -0.561 . . . . 0.0 111.221 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.71 -40.33 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.518 0.727 . . . . 0.0 112.16 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.45 -41.95 99.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.955 -1.091 . . . . 0.0 112.183 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t -67.1 -50.46 61.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 0.0 112.38 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.44 -33.32 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.099 -1.0 . . . . 0.0 112.54 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -58.34 -34.12 70.29 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.649 1.18 . . . . 0.0 113.729 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -74.02 -15.39 61.09 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.271 1.428 . . . . 0.0 113.688 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.33 1.852 . . . . 0.0 111.371 -173.816 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.668 0.747 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -69.42 -36.94 77.19 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.809 -1.182 . . . . 0.0 112.479 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -55.95 -45.56 78.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.86 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.93 -44.56 96.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.934 0.894 . . . . 0.0 111.931 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.26 -51.01 71.08 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.198 0.454 . . . . 0.0 111.611 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.86 -40.52 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.723 1.209 . . . . 0.0 111.116 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmt -60.8 -46.13 91.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.028 0.831 . . . . 0.0 112.519 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.16 -53.69 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.899 0.879 . . . . 0.0 111.155 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.17 -29.19 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.26 -31.85 78.59 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.482 1.515 . . . . 0.0 113.277 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.18 -43.41 80.49 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.408 1.104 . . . . 0.0 111.955 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -55.99 26.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.0 -37.66 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.581 0.752 . . . . 0.0 111.281 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.9 -34.73 38.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.91 1.719 . . . . 0.0 114.142 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.16 -33.86 63.31 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.255 1.022 . . . . 0.0 112.529 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -58.94 -43.33 91.21 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.431 1.014 . . . . 0.0 112.275 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.78 -49.68 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.312 1.045 . . . . 0.0 110.769 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.16 -43.15 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.636 0.774 . . . . 0.0 111.558 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.94 -41.01 95.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.301 1.04 . . . . 0.0 111.956 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.66 79.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.447 0.699 . . . . 0.0 111.709 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.5 -41.35 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 111.613 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.09 -42.51 98.64 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.963 -1.086 . . . . 0.0 112.707 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 m -66.67 -51.42 56.26 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.579 0.752 . . . . 0.0 112.274 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.82 -33.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 119.48 1.036 . . . . 0.0 112.519 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -56.58 -34.03 66.76 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.115 0.966 . . . . 0.0 112.648 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.0 -15.23 58.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.7 pttt . . . . . 0 C--O 1.254 1.297 0 CA-C-O 117.069 -1.443 . . . . 0.0 113.749 -176.056 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -60.75 -34.83 75.02 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.107 1.321 . . . . 0.0 114.345 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -56.61 -47.16 80.23 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.337 1.055 . . . . 0.0 112.575 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.16 -42.35 94.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.573 1.149 . . . . 0.0 111.979 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.2 -48.77 77.96 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.472 0.578 . . . . 0.0 111.412 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.73 -38.99 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.075 1.35 . . . . 0.0 111.266 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.4 mtt -59.81 -41.54 91.48 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.389 0.995 . . . . 0.0 112.39 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.97 -53.78 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.13 0.972 . . . . 0.0 110.69 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.69 -26.22 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.0 -27.72 62.69 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.543 1.544 . . . . 0.0 113.97 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 -52.61 30.15 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 118.469 1.134 . . . . 0.0 111.187 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -55.0 39.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.399 1.479 . . . . 0.0 113.369 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.06 -31.14 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.839 0.856 . . . . 0.0 111.531 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.12 -36.13 27.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.652 1.596 . . . . 0.0 113.911 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -37.98 76.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.423 1.111 . . . . 0.0 113.023 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -62.44 -45.4 93.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.345 1.058 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 mt -64.07 -47.23 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.23 1.412 . . . . 0.0 109.564 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.77 -41.94 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.36 1.064 . . . . 0.0 111.901 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -45.96 92.04 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.756 0.822 . . . . 0.0 112.356 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 -44.18 94.11 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.796 0.838 . . . . 0.0 112.274 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.72 -41.59 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.285 1.034 . . . . 0.0 111.486 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.64 -42.07 98.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.974 -1.079 . . . . 0.0 112.217 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.7 m -64.7 -49.29 71.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.778 0.831 . . . . 0.0 112.584 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.05 -30.79 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.219 0.918 . . . . 0.0 112.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -60.71 -28.04 68.35 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.388 1.075 . . . . 0.0 113.844 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -78.07 -15.12 59.18 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.29 1.436 . . . . 0.0 113.639 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.585 1.554 . . . . 0.0 112.428 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -51.34 -32.37 25.23 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.998 1.719 . . . . 0.0 115.617 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -56.78 -37.23 70.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.161 1.384 . . . . 0.0 112.906 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.62 -45.21 72.49 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.104 1.362 . . . . 0.0 111.448 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.38 -52.2 66.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.126 0.57 . . . . 0.0 111.889 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -39.85 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.282 1.433 . . . . 0.0 110.795 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 mmm -59.73 -51.39 69.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.915 . . . . 0.0 111.977 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.84 -51.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.595 0.758 . . . . 0.0 111.368 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 m -67.85 -37.55 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.157 0.583 . . . . 0.0 111.977 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.77 99.52 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.545 1.545 . . . . 0.0 112.811 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.17 -45.82 93.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 117.949 0.874 . . . . 0.0 111.913 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -51.71 67.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.903 1.281 . . . . 0.0 112.871 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.47 -44.47 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.066 0.546 . . . . 0.0 111.777 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.77 64.83 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.296 0.951 . . . . 0.0 114.162 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -40.18 67.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.672 1.236 . . . . 0.0 111.886 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -58.88 -36.95 75.49 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.787 1.235 . . . . 0.0 111.875 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.85 -50.03 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.551 1.541 . . . . 0.0 110.692 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.63 -44.91 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.963 0.905 . . . . 0.0 111.722 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.8 -37.82 85.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.983 0.913 . . . . 0.0 112.478 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.28 86.12 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.545 0.611 . . . . 0.0 111.471 174.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.38 -41.81 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.287 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.54 -42.28 96.22 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.891 -1.131 . . . . 0.0 112.544 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -66.87 -49.51 65.42 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.292 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.6 tt -63.32 -35.75 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.583 1.083 . . . . 0.0 112.454 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -35.74 69.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.554 1.141 . . . . 0.0 111.996 174.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.53 -11.52 59.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.108 1.763 . . . . 0.0 114.253 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 116.992 -1.48 . . . . 0.0 113.243 -178.49 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.9 pttp . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -54.93 -30.56 58.89 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 121.152 1.796 . . . . 0.0 115.468 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -53.01 -44.73 67.5 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.577 1.551 . . . . 0.0 111.718 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.96 -45.21 86.66 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.791 1.236 . . . . 0.0 111.432 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.11 -52.85 63.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 111.244 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.38 -42.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.977 1.311 . . . . 0.0 111.151 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -46.45 80.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.237 1.015 . . . . 0.0 112.475 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.05 -53.9 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.23 1.012 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.1 -27.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.93 -25.52 64.18 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.735 1.636 . . . . 0.0 113.819 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.02 -54.04 15.93 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.636 1.218 . . . . 0.0 110.589 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -54.67 43.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.636 1.574 . . . . 0.0 113.287 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.47 -35.47 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.38 1.072 . . . . 0.0 111.475 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.94 96.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.041 0.829 . . . . 0.0 112.252 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -44.36 66.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.899 1.279 . . . . 0.0 112.106 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -43.57 76.33 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.949 1.3 . . . . 0.0 112.55 175.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.82 -47.69 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.847 1.259 . . . . 0.0 109.903 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.7 -40.01 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.758 -0.589 . . . . 0.0 112.023 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -42.24 92.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.264 1.026 . . . . 0.0 112.333 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.96 87.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.726 0.81 . . . . 0.0 111.854 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.7 -41.96 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 111.901 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.7 -40.59 95.58 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.017 -1.052 . . . . 0.0 112.385 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -66.62 -51.53 55.27 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.762 0.825 . . . . 0.0 112.101 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 tt -63.72 -32.43 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.391 -0.818 . . . . 0.0 112.61 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -56.97 -36.79 70.73 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.394 1.477 . . . . 0.0 113.372 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -11.85 58.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.224 1.41 . . . . 0.0 113.556 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.275 0 C-N-CA 127.364 2.266 . . . . 0.0 112.866 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -49.93 -36.53 28.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 125.843 1.657 . . . . 0.0 114.702 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -54.31 -38.73 66.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.959 1.304 . . . . 0.0 113.676 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.17 -39.61 71.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.279 1.032 . . . . 0.0 111.951 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.18 -48.83 79.09 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.426 0.557 . . . . 0.0 111.463 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.5 mt -57.94 -39.71 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.004 1.321 . . . . 0.0 110.978 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.03 -38.3 88.18 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.27 -0.894 . . . . 0.0 113.395 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.9 mt -65.31 -53.86 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.009 0.924 . . . . 0.0 110.459 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.33 -22.07 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.56 -26.22 59.42 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.869 1.7 . . . . 0.0 114.402 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.9 8.66 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.673 1.236 . . . . 0.0 111.232 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -57.3 9.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.765 1.626 . . . . 0.0 113.381 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.79 -34.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.76 -26.86 58.31 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.521 1.058 . . . . 0.0 114.215 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -41.22 76.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.924 1.362 . . . . 0.0 111.534 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -59.8 -44.08 94.16 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.853 0.861 . . . . 0.0 112.629 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.3 mt -65.64 -51.82 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.213 1.405 . . . . 0.0 109.566 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.32 -43.12 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.922 1.289 . . . . 0.0 111.752 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.32 -42.65 99.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.303 1.041 . . . . 0.0 112.353 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.1 97.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.525 -0.734 . . . . 0.0 111.715 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.07 -35.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.588 1.155 . . . . 0.0 111.716 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.0 -45.23 78.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.673 -1.267 . . . . 0.0 110.754 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 m -62.72 -47.43 83.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.386 1.074 . . . . 0.0 112.472 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 tt -66.82 -35.75 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 118.962 0.801 . . . . 0.0 112.571 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -59.87 -24.48 64.28 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.087 1.312 . . . . 0.0 113.461 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -71.11 -30.25 66.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.99 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -160.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -54.78 -46.32 74.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.698 1.599 . . . . 0.0 112.968 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.76 -45.12 91.24 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.932 0.893 . . . . 0.0 111.87 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.06 -50.08 74.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.385 0.539 . . . . 0.0 111.763 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -58.08 -37.32 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.213 1.405 . . . . 0.0 110.852 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.6 mtt -61.95 -44.32 97.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.83 1.196 . . . . 0.0 112.228 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.46 -53.71 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.025 0.93 . . . . 0.0 110.729 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.38 -27.98 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.23 -40.61 99.25 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.532 1.539 . . . . 0.0 112.989 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.16 94.35 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 118.04 0.92 . . . . 0.0 112.256 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 125.552 1.541 . . . . 0.0 112.233 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.75 -44.58 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.055 0.942 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.5 -45.79 92.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.495 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.4 81.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.363 0.665 . . . . 0.0 112.104 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.18 -39.97 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.072 0.949 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.24 -42.64 99.24 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.798 -1.189 . . . . 0.0 111.992 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -63.26 -51.53 65.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 112.193 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -64.41 -31.63 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.308 -0.87 . . . . 0.0 112.653 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -34.85 76.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.827 1.251 . . . . 0.0 112.561 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 124.259 1.024 . . . . 0.0 112.659 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -52.66 -41.32 63.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.929 1.291 . . . . 0.0 113.003 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.83 -47.7 65.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.111 1.764 . . . . 0.0 111.651 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.79 -49.33 76.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.388 0.54 . . . . 0.0 111.96 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.37 -37.11 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 111.167 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -43.33 97.5 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.426 1.012 . . . . 0.0 112.801 175.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.85 -53.67 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.481 0.712 . . . . 0.0 110.846 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.99 -34.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.018 0.527 . . . . 0.0 112.4 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.53 77.48 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.426 1.489 . . . . 0.0 113.838 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.85 -56.59 12.16 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.058 0.929 . . . . 0.0 111.6 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 125.397 1.479 . . . . 0.0 113.629 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -57.44 -40.35 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.858 0.863 . . . . 0.0 111.954 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -43.24 91.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.137 0.975 . . . . 0.0 112.277 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.56 84.86 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.794 0.838 . . . . 0.0 111.591 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.97 -41.16 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.83 -43.43 94.58 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.905 -1.122 . . . . 0.0 112.007 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 t -67.32 -48.14 68.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.589 0.756 . . . . 0.0 112.394 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.9 tt -64.15 -31.86 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.372 -0.83 . . . . 0.0 112.453 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -61.49 -40.51 94.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.27 0.941 . . . . 0.0 112.531 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.5 mttt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 175.101 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -53.98 -42.95 69.55 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.572 1.549 . . . . 0.0 113.056 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.58 -47.93 83.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.287 1.035 . . . . 0.0 112.156 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.09 -51.75 68.7 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.915 -0.491 . . . . 0.0 111.65 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -54.86 -39.51 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.547 1.539 . . . . 0.0 111.276 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -48.84 80.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.186 0.995 . . . . 0.0 111.989 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.3 mt -65.13 -53.82 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 110.977 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -69.28 -34.04 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.62 90.42 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.701 1.619 . . . . 0.0 112.897 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -49.32 59.82 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.273 1.037 . . . . 0.0 111.049 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 126.062 1.745 . . . . 0.0 113.371 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.8 -40.58 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.738 . . . . 0.0 111.701 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -61.58 -38.32 87.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.358 1.063 . . . . 0.0 112.468 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.55 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.425 0.69 . . . . 0.0 111.349 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.1 -42.3 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.607 1.163 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.84 -39.88 95.72 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.747 -1.221 . . . . 0.0 112.302 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.27 -51.44 60.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.268 1.027 . . . . 0.0 112.136 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.8 -34.4 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.289 -0.882 . . . . 0.0 112.546 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -56.33 -31.76 64.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.978 1.311 . . . . 0.0 113.585 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.9 tttm . . . . . 0 N--CA 1.474 0.764 0 C-N-CA 124.807 1.243 . . . . 0.0 113.779 177.742 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tptm . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -52.69 -43.46 65.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.497 1.519 . . . . 0.0 113.032 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -64.6 -46.52 82.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 111.509 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -56.59 -50.75 71.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.999 0.519 . . . . 0.0 111.472 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.21 -42.82 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.443 1.097 . . . . 0.0 111.07 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.84 -44.81 93.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.41 1.005 . . . . 0.0 112.815 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.96 -53.78 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.857 0.863 . . . . 0.0 111.159 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.0 m -69.39 -24.78 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.64 -31.18 66.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.39 1.472 . . . . 0.0 113.54 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.25 75.79 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.391 1.095 . . . . 0.0 111.734 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 125.421 1.488 . . . . 0.0 112.992 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.93 -41.56 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.829 0.852 . . . . 0.0 111.78 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.89 -40.61 96.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.851 0.86 . . . . 0.0 112.685 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.83 91.75 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.734 -0.604 . . . . 0.0 111.673 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.73 -42.38 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.792 0.837 . . . . 0.0 111.962 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.01 -33.97 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.527 -1.358 . . . . 0.0 113.371 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -72.34 -50.94 23.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.095 0.958 . . . . 0.0 111.782 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.62 -31.69 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.244 -0.91 . . . . 0.0 112.951 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -58.52 -30.89 67.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.921 -1.112 . . . . 0.0 113.721 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mttp . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 175.079 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -52.33 -53.79 39.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.268 1.427 . . . . 0.0 111.862 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.96 -45.99 89.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.45 1.5 . . . . 0.0 112.032 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -55.25 -50.09 70.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.376 0.671 . . . . 0.0 111.504 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mt -58.16 -38.15 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.678 1.191 . . . . 0.0 111.315 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.9 mtp -64.98 -43.5 92.4 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.476 1.035 . . . . 0.0 112.643 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.26 -53.71 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.971 0.908 . . . . 0.0 110.723 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.03 -26.84 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.4 -37.0 79.45 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.567 1.556 . . . . 0.0 113.022 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.97 -51.87 55.87 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.671 0.736 . . . . 0.0 111.404 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 126.177 1.791 . . . . 0.0 113.348 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.2 -45.23 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.303 1.041 . . . . 0.0 112.04 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.09 -42.97 91.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 112.482 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.53 79.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.171 0.589 . . . . 0.0 111.493 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.94 -41.89 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.154 0.582 . . . . 0.0 112.112 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.32 -44.21 95.66 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 t -63.88 -51.5 64.26 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.755 0.822 . . . . 0.0 111.791 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.8 tt -63.45 -30.85 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.292 -0.88 . . . . 0.0 112.643 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -40.86 97.89 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.411 1.084 . . . . 0.0 112.036 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 125.066 1.346 . . . . 0.0 113.723 174.947 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -51.54 -39.77 58.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.205 1.802 . . . . 0.0 113.742 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.04 -31.53 71.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.414 1.086 . . . . 0.0 112.474 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -66.01 -50.77 63.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.497 0.665 . . . . 0.0 110.486 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.7 mt -62.07 -35.86 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.578 1.551 . . . . 0.0 110.851 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -56.35 -39.47 72.9 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.711 1.204 . . . . 0.0 112.516 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.9 mt -68.92 -53.85 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.377 1.071 . . . . 0.0 110.597 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.96 -29.6 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.392 0.677 . . . . 0.0 112.727 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.09 67.6 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.849 1.214 . . . . 0.0 114.284 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.54 -52.06 37.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.708 1.254 . . . . 0.0 111.849 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 125.498 1.519 . . . . 0.0 112.9 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.49 -42.2 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.527 1.131 . . . . 0.0 111.869 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.52 -44.14 97.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.716 1.606 . . . . 0.0 112.692 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -45.58 88.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.131 0.573 . . . . 0.0 111.612 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.47 -40.48 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.373 1.069 . . . . 0.0 111.8 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.34 -43.45 98.79 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.668 -1.27 . . . . 0.0 112.481 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.5 m -63.94 -51.16 65.72 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.188 0.995 . . . . 0.0 112.16 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.48 -31.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.845 0.748 . . . . 0.0 112.43 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.26 -40.43 95.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.438 1.017 . . . . 0.0 112.505 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptt . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 175.193 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -57.13 -44.79 83.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.308 1.043 . . . . 0.0 112.112 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -44.77 95.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.683 1.193 . . . . 0.0 111.696 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.57 -51.53 69.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.271 0.487 . . . . 0.0 111.761 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.93 -39.82 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.875 1.27 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.81 -47.55 85.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.238 0.926 . . . . 0.0 112.609 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.61 -53.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.0 0.92 . . . . 0.0 110.783 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.8 m -66.36 -38.68 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.144 0.578 . . . . 0.0 112.255 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.83 -32.59 84.69 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.336 1.446 . . . . 0.0 113.38 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.21 -53.27 41.02 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.374 1.087 . . . . 0.0 112.078 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.983 1.313 . . . . 0.0 113.159 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -56.19 -40.5 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.017 0.927 . . . . 0.0 111.551 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -43.96 98.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.749 0.819 . . . . 0.0 112.613 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.76 90.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.729 0.811 . . . . 0.0 111.925 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.8 -40.64 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.966 0.906 . . . . 0.0 111.825 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.95 -42.86 99.59 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.872 -1.142 . . . . 0.0 112.041 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.0 t -63.16 -51.48 66.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.404 0.682 . . . . 0.0 112.066 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tt -66.22 -26.45 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.359 -0.838 . . . . 0.0 112.687 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -66.05 -39.58 90.23 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.92 -1.112 . . . . 0.0 112.763 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.122 0.969 . . . . 0.0 112.362 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -54.72 -44.04 73.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.465 1.106 . . . . 0.0 112.97 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.62 -45.27 91.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.483 1.113 . . . . 0.0 111.816 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.92 -50.95 71.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.031 0.532 . . . . 0.0 111.784 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.86 -40.29 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.654 1.582 . . . . 0.0 111.152 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.29 -42.0 98.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.346 0.975 . . . . 0.0 113.485 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.99 -53.84 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.02 0.827 . . . . 0.0 110.612 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.81 -30.67 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.93 -30.78 70.54 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.795 1.664 . . . . 0.0 113.762 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.81 -56.92 6.18 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.172 0.986 . . . . 0.0 110.945 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 125.788 1.635 . . . . 0.0 113.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -55.67 -44.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.458 0.703 . . . . 0.0 111.651 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -44.43 97.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.346 0.659 . . . . 0.0 112.327 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.64 91.2 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.725 0.81 . . . . 0.0 112.496 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.43 -42.43 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.701 0.8 . . . . 0.0 111.406 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -58.22 -44.41 88.17 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.15 -0.969 . . . . 0.0 112.082 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -64.55 -51.51 62.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.733 0.813 . . . . 0.0 112.547 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.1 -30.34 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.2 -0.937 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -42.04 95.37 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.647 1.179 . . . . 0.0 112.203 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 125.703 1.601 . . . . 0.0 113.621 177.112 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -58.15 -38.45 76.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.122 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.31 -42.14 72.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.071 0.948 . . . . 0.0 111.365 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.89 -51.42 69.71 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.329 0.513 . . . . 0.0 111.365 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.0 mt -55.72 -43.11 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.98 1.312 . . . . 0.0 111.211 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -58.27 -46.57 85.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.777 0.831 . . . . 0.0 112.494 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.18 -53.82 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.0 0.92 . . . . 0.0 111.106 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.37 -24.14 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.3 -22.89 51.99 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.795 1.664 . . . . 0.0 113.514 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.96 -57.96 4.62 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.417 1.108 . . . . 0.0 110.37 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 125.642 1.577 . . . . 0.0 113.744 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.2 mt . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.67 -40.12 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.143 0.977 . . . . 0.0 111.893 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.59 -45.32 94.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.207 1.003 . . . . 0.0 112.031 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.65 93.43 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 0.0 111.997 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.0 -41.25 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.168 0.987 . . . . 0.0 111.669 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.98 -41.36 97.93 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.825 -1.172 . . . . 0.0 112.427 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 m -64.85 -51.51 61.65 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.67 0.788 . . . . 0.0 112.386 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -64.7 -32.42 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.108 0.867 . . . . 0.0 112.467 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.66 -32.47 63.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.067 1.347 . . . . 0.0 113.17 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -54.8 -45.98 74.42 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.538 1.135 . . . . 0.0 112.358 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.84 -42.92 84.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.13 1.372 . . . . 0.0 112.329 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -58.15 -53.01 63.15 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.451 0.569 . . . . 0.0 111.392 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -56.06 -40.84 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.806 1.642 . . . . 0.0 110.94 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.8 mmm -57.2 -47.83 80.29 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.09 0.956 . . . . 0.0 112.335 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.02 -53.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.811 0.844 . . . . 0.0 111.284 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.12 -30.42 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.49 -19.63 71.0 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.724 1.63 . . . . 0.0 113.675 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.71 -50.16 20.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.01 1.405 . . . . 0.0 110.559 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 126.024 1.73 . . . . 0.0 112.803 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -56.78 -40.81 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.371 1.468 . . . . 0.0 111.672 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.99 -43.8 98.34 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.984 0.914 . . . . 0.0 112.332 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.08 92.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.5 -40.37 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.003 0.921 . . . . 0.0 111.824 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.6 mt -62.91 -43.54 98.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.011 -1.056 . . . . 0.0 111.607 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -64.4 -49.06 73.05 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.568 0.747 . . . . 0.0 112.173 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.24 -34.21 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.8 0.727 . . . . 0.0 112.583 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.41 -31.45 65.85 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.305 1.442 . . . . 0.0 113.939 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 125.162 1.385 . . . . 0.0 113.655 176.228 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -55.31 -50.21 70.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.202 1.401 . . . . 0.0 112.792 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.63 -43.52 98.71 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 111.336 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -56.31 -47.73 78.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.714 0.688 . . . . 0.0 111.903 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.05 -40.25 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 111.312 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 mtp -64.67 -41.12 96.3 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.251 -0.906 . . . . 0.0 113.186 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -62.12 -53.66 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.247 1.019 . . . . 0.0 110.768 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.81 -29.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.82 93.48 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.683 1.135 . . . . 0.0 112.9 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.55 89.85 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.078 0.939 . . . . 0.0 112.149 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.315 1.446 . . . . 0.0 112.89 175.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -58.14 -42.11 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.801 0.84 . . . . 0.0 111.627 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -44.63 93.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.001 0.92 . . . . 0.0 112.28 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -36.62 80.57 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.862 0.865 . . . . 0.0 112.689 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.34 -40.02 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.115 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.31 -44.86 95.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.877 -1.139 . . . . 0.0 112.418 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -66.08 -47.6 73.71 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.771 0.714 . . . . 0.0 112.827 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.18 -33.07 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.356 0.98 . . . . 0.0 112.453 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -62.37 -39.01 91.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.004 0.922 . . . . 0.0 111.856 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 124.715 1.206 . . . . 0.0 113.157 177.618 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -55.22 -42.94 74.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.838 1.255 . . . . 0.0 112.997 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.61 -42.69 91.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 111.55 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -60.22 -49.15 78.75 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.678 0.791 . . . . 0.0 112.14 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -55.01 -45.0 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.265 1.426 . . . . 0.0 111.03 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.5 mmm -56.56 -42.93 79.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.194 0.998 . . . . 0.0 112.905 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.68 -53.8 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.05 0.94 . . . . 0.0 111.252 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.27 -26.98 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.82 -30.41 66.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.43 1.014 . . . . 0.0 113.471 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.81 -51.65 33.86 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.308 1.054 . . . . 0.0 111.737 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.884 1.673 . . . . 0.0 112.793 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -58.56 -41.46 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.748 0.819 . . . . 0.0 112.08 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.53 -42.43 96.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.73 1.212 . . . . 0.0 112.649 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.96 92.15 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.628 0.771 . . . . 0.0 111.875 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.33 -40.05 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.104 0.962 . . . . 0.0 111.716 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mt -60.85 -44.83 96.46 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.45 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 t -62.99 -51.58 66.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.915 0.886 . . . . 0.0 112.096 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -63.41 -33.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.319 -0.863 . . . . 0.0 112.518 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -61.98 -27.95 69.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.226 1.011 . . . . 0.0 113.036 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -50.73 -43.37 58.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.238 1.815 . . . . 0.0 112.469 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 31.6 mt -69.47 -42.51 74.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.16 1.384 . . . . 0.0 111.544 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -56.54 -47.64 79.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.299 0.64 . . . . 0.0 111.605 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.6 mt -54.45 -43.22 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.807 1.243 . . . . 0.0 111.339 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtm -60.84 -46.37 90.81 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.428 -0.795 . . . . 0.0 112.502 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.13 -53.68 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.308 1.043 . . . . 0.0 110.963 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 m -65.4 -29.8 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.74 87.38 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.869 1.224 . . . . 0.0 113.802 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.63 -46.5 93.6 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 118.323 1.061 . . . . 0.0 112.667 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.803 1.641 . . . . 0.0 112.722 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.7 -49.28 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.096 0.958 . . . . 0.0 111.52 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.55 -44.82 93.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.676 0.79 . . . . 0.0 112.813 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.13 83.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.455 0.702 . . . . 0.0 112.614 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.85 -41.89 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.265 1.026 . . . . 0.0 111.413 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.1 -43.2 95.72 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.874 -1.141 . . . . 0.0 112.275 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m -63.39 -51.41 65.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.476 0.711 . . . . 0.0 112.851 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.1 tt -64.72 -33.05 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.242 0.928 . . . . 0.0 112.859 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -61.07 -42.48 98.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 0.0 112.178 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 125.639 1.575 . . . . 0.0 114.828 176.254 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -57.2 -46.16 83.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.122 0.969 . . . . 0.0 112.907 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.15 -42.79 95.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.516 1.126 . . . . 0.0 112.113 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -58.31 -49.93 75.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.647 0.658 . . . . 0.0 111.647 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.38 -40.01 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.572 1.149 . . . . 0.0 111.527 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.5 mmt -59.33 -42.17 90.84 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.479 1.036 . . . . 0.0 112.843 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.29 -53.57 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.389 0.676 . . . . 0.0 111.013 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.21 -35.42 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.57 82.83 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.564 1.554 . . . . 0.0 112.616 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.28 58.22 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 125.926 1.691 . . . . 0.0 113.635 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.16 -41.97 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.892 1.277 . . . . 0.0 111.666 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -45.05 95.3 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.773 1.229 . . . . 0.0 112.344 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.05 -45.69 90.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.421 0.688 . . . . 0.0 112.055 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.75 -42.6 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.73 1.212 . . . . 0.0 111.393 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.3 -43.84 95.93 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.91 -1.119 . . . . 0.0 111.788 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.5 m -64.05 -50.77 67.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 112.681 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.73 -30.86 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.044 0.838 . . . . 0.0 112.614 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -61.14 -43.19 99.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.562 1.145 . . . . 0.0 111.636 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 0.0 113.924 177.729 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -56.5 -45.79 80.86 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.937 1.295 . . . . 0.0 112.241 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.81 -43.47 96.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.788 1.235 . . . . 0.0 111.569 175.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -57.42 -49.8 75.05 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.578 -0.701 . . . . 0.0 111.775 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mt -58.38 -39.12 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.894 1.278 . . . . 0.0 111.056 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmm -61.3 -43.59 98.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.663 0.785 . . . . 0.0 112.291 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.85 -53.58 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.794 0.838 . . . . 0.0 111.07 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.8 -38.21 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.979 0.511 . . . . 0.0 112.231 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.38 91.37 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.43 1.49 . . . . 0.0 112.915 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -47.87 84.98 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.179 0.99 . . . . 0.0 111.862 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 124.328 1.051 . . . . 0.0 113.093 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.65 -42.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.146 0.978 . . . . 0.0 111.848 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.37 -40.93 96.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.818 0.847 . . . . 0.0 112.296 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.37 97.43 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.802 -0.561 . . . . 0.0 111.221 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.71 -40.33 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.518 0.727 . . . . 0.0 112.16 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.45 -41.95 99.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.955 -1.091 . . . . 0.0 112.183 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t -67.1 -50.46 61.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 0.0 112.38 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.44 -33.32 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.099 -1.0 . . . . 0.0 112.54 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -58.34 -34.12 70.29 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.649 1.18 . . . . 0.0 113.729 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm . . . . . 0 N--CA 1.476 0.851 0 C-N-CA 125.271 1.428 . . . . 0.0 113.688 175.147 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -55.95 -45.56 78.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.86 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.93 -44.56 96.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.934 0.894 . . . . 0.0 111.931 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.26 -51.01 71.08 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.198 0.454 . . . . 0.0 111.611 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.86 -40.52 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.723 1.209 . . . . 0.0 111.116 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmt -60.8 -46.13 91.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.028 0.831 . . . . 0.0 112.519 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.16 -53.69 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.899 0.879 . . . . 0.0 111.155 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.17 -29.19 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.26 -31.85 78.59 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.482 1.515 . . . . 0.0 113.277 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.18 -43.41 80.49 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.408 1.104 . . . . 0.0 111.955 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.769 -0.085 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.16 -43.15 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.636 0.774 . . . . 0.0 111.558 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.94 -41.01 95.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.301 1.04 . . . . 0.0 111.956 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.66 79.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.447 0.699 . . . . 0.0 111.709 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.5 -41.35 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 111.613 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.09 -42.51 98.64 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.963 -1.086 . . . . 0.0 112.707 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 m -66.67 -51.42 56.26 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.579 0.752 . . . . 0.0 112.274 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.82 -33.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 119.48 1.036 . . . . 0.0 112.519 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -56.58 -34.03 66.76 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.115 0.966 . . . . 0.0 112.648 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -56.61 -47.16 80.23 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.337 1.055 . . . . 0.0 112.575 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.16 -42.35 94.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.573 1.149 . . . . 0.0 111.979 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.2 -48.77 77.96 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.472 0.578 . . . . 0.0 111.412 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.73 -38.99 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.075 1.35 . . . . 0.0 111.266 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.4 mtt -59.81 -41.54 91.48 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.389 0.995 . . . . 0.0 112.39 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.97 -53.78 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.13 0.972 . . . . 0.0 110.69 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.69 -26.22 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.0 -27.72 62.69 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.543 1.544 . . . . 0.0 113.97 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 -52.61 30.15 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 118.469 1.134 . . . . 0.0 111.187 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.399 1.479 . . . . 0.0 113.369 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.77 -41.94 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.36 1.064 . . . . 0.0 111.901 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -45.96 92.04 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.756 0.822 . . . . 0.0 112.356 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 -44.18 94.11 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.796 0.838 . . . . 0.0 112.274 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.72 -41.59 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.285 1.034 . . . . 0.0 111.486 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.64 -42.07 98.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.974 -1.079 . . . . 0.0 112.217 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.7 m -64.7 -49.29 71.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.778 0.831 . . . . 0.0 112.584 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.05 -30.79 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.219 0.918 . . . . 0.0 112.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -60.71 -28.04 68.35 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.388 1.075 . . . . 0.0 113.844 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt . . . . . 0 N--CA 1.478 0.945 0 C-N-CA 125.29 1.436 . . . . 0.0 113.639 175.038 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -56.78 -37.23 70.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.161 1.384 . . . . 0.0 112.906 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.62 -45.21 72.49 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.104 1.362 . . . . 0.0 111.448 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.38 -52.2 66.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.126 0.57 . . . . 0.0 111.889 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -39.85 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.282 1.433 . . . . 0.0 110.795 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 mmm -59.73 -51.39 69.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.915 . . . . 0.0 111.977 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.84 -51.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.595 0.758 . . . . 0.0 111.368 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 m -67.85 -37.55 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.157 0.583 . . . . 0.0 111.977 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.77 99.52 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.545 1.545 . . . . 0.0 112.811 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.17 -45.82 93.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 117.949 0.874 . . . . 0.0 111.913 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.903 1.281 . . . . 0.0 112.871 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.63 -44.91 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.963 0.905 . . . . 0.0 111.722 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.8 -37.82 85.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.983 0.913 . . . . 0.0 112.478 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.28 86.12 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.545 0.611 . . . . 0.0 111.471 174.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' HG22 ' A' ' 24' ' ' ILE . 43.3 t -66.38 -41.81 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.287 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.54 -42.28 96.22 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.891 -1.131 . . . . 0.0 112.544 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -66.87 -49.51 65.42 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.292 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.413 HG22 ' HA ' ' A' ' 21' ' ' VAL . 13.6 tt -63.32 -35.75 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.583 1.083 . . . . 0.0 112.454 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -35.74 69.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.554 1.141 . . . . 0.0 111.996 174.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.7 tttt . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 126.108 1.763 . . . . 0.0 114.253 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -53.01 -44.73 67.5 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.577 1.551 . . . . 0.0 111.718 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.96 -45.21 86.66 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.791 1.236 . . . . 0.0 111.432 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.11 -52.85 63.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 111.244 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.38 -42.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.977 1.311 . . . . 0.0 111.151 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -46.45 80.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.237 1.015 . . . . 0.0 112.475 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.05 -53.9 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.23 1.012 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.1 -27.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.93 -25.52 64.18 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.735 1.636 . . . . 0.0 113.819 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.02 -54.04 15.93 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.636 1.218 . . . . 0.0 110.589 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.636 1.574 . . . . 0.0 113.287 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.7 -40.01 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.758 -0.589 . . . . 0.0 112.023 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -42.24 92.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.264 1.026 . . . . 0.0 112.333 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.96 87.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.726 0.81 . . . . 0.0 111.854 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.7 -41.96 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 111.901 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.7 -40.59 95.58 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.017 -1.052 . . . . 0.0 112.385 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -66.62 -51.53 55.27 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.762 0.825 . . . . 0.0 112.101 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 tt -63.72 -32.43 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.391 -0.818 . . . . 0.0 112.61 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -56.97 -36.79 70.73 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.394 1.477 . . . . 0.0 113.372 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 C-N-CA 125.224 1.41 . . . . 0.0 113.556 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -54.31 -38.73 66.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.959 1.304 . . . . 0.0 113.676 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.17 -39.61 71.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.279 1.032 . . . . 0.0 111.951 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.18 -48.83 79.09 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.426 0.557 . . . . 0.0 111.463 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.5 mt -57.94 -39.71 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.004 1.321 . . . . 0.0 110.978 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.03 -38.3 88.18 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.27 -0.894 . . . . 0.0 113.395 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.9 mt -65.31 -53.86 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.009 0.924 . . . . 0.0 110.459 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.33 -22.07 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.56 -26.22 59.42 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.869 1.7 . . . . 0.0 114.402 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.9 8.66 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.673 1.236 . . . . 0.0 111.232 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 125.765 1.626 . . . . 0.0 113.381 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.32 -43.12 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.922 1.289 . . . . 0.0 111.752 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.32 -42.65 99.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.303 1.041 . . . . 0.0 112.353 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.1 97.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.525 -0.734 . . . . 0.0 111.715 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.07 -35.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.588 1.155 . . . . 0.0 111.716 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.0 -45.23 78.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.673 -1.267 . . . . 0.0 110.754 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 m -62.72 -47.43 83.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.386 1.074 . . . . 0.0 112.472 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 tt -66.82 -35.75 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 118.962 0.801 . . . . 0.0 112.571 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -59.87 -24.48 64.28 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.087 1.312 . . . . 0.0 113.461 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.99 175.374 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 pttm . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -59.04 -35.53 73.47 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 0.0 113.704 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -54.78 -46.32 74.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.698 1.599 . . . . 0.0 112.968 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.76 -45.12 91.24 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.932 0.893 . . . . 0.0 111.87 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.06 -50.08 74.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.385 0.539 . . . . 0.0 111.763 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -58.08 -37.32 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.213 1.405 . . . . 0.0 110.852 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.6 mtt -61.95 -44.32 97.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.83 1.196 . . . . 0.0 112.228 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.46 -53.71 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.025 0.93 . . . . 0.0 110.729 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.38 -27.98 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.23 -40.61 99.25 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.532 1.539 . . . . 0.0 112.989 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.16 94.35 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 118.04 0.92 . . . . 0.0 112.256 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -57.28 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.552 1.541 . . . . 0.0 112.233 174.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.17 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.466 1.106 . . . . 0.0 111.492 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.66 27.57 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.647 1.594 . . . . 0.0 114.522 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -35.71 65.81 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.734 1.267 . . . . 0.0 111.686 175.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -58.17 -46.04 86.44 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.223 1.009 . . . . 0.0 112.008 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 62.1 mt -70.35 -48.67 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.234 1.414 . . . . 0.0 109.98 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.75 -44.58 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.055 0.942 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.5 -45.79 92.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.495 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.4 81.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.363 0.665 . . . . 0.0 112.104 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.18 -39.97 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.072 0.949 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.24 -42.64 99.24 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.798 -1.189 . . . . 0.0 111.992 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -63.26 -51.53 65.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 112.193 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -64.41 -31.63 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.308 -0.87 . . . . 0.0 112.653 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -34.85 76.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.827 1.251 . . . . 0.0 112.561 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -26.66 62.23 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.259 1.024 . . . . 0.0 112.659 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.946 1.698 . . . . 0.0 113.477 179.054 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -60.91 -46.57 90.11 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 121.219 1.827 . . . . 0.0 113.826 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -52.66 -41.32 63.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.929 1.291 . . . . 0.0 113.003 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.83 -47.7 65.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.111 1.764 . . . . 0.0 111.651 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.79 -49.33 76.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.388 0.54 . . . . 0.0 111.96 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.37 -37.11 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 111.167 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -43.33 97.5 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.426 1.012 . . . . 0.0 112.801 175.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.85 -53.67 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.481 0.712 . . . . 0.0 110.846 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.99 -34.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.018 0.527 . . . . 0.0 112.4 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.53 77.48 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.426 1.489 . . . . 0.0 113.838 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.85 -56.59 12.16 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.058 0.929 . . . . 0.0 111.6 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -51.63 69.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.397 1.479 . . . . 0.0 113.629 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.68 -38.65 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.123 1.369 . . . . 0.0 111.326 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.41 92.9 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.078 0.847 . . . . 0.0 113.029 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -37.51 68.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.538 1.135 . . . . 0.0 113.084 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -58.61 -41.52 86.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.255 1.022 . . . . 0.0 112.372 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.68 -48.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.52 1.128 . . . . 0.0 109.952 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -57.44 -40.35 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.858 0.863 . . . . 0.0 111.954 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -43.24 91.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.137 0.975 . . . . 0.0 112.277 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.56 84.86 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.794 0.838 . . . . 0.0 111.591 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.97 -41.16 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.83 -43.43 94.58 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.905 -1.122 . . . . 0.0 112.007 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 t -67.32 -48.14 68.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.589 0.756 . . . . 0.0 112.394 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.9 tt -64.15 -31.86 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.372 -0.83 . . . . 0.0 112.453 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -61.49 -40.51 94.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.27 0.941 . . . . 0.0 112.531 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -68.43 -22.28 64.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.452 1.101 . . . . 0.0 112.541 179.582 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.629 0.252 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -64.57 -37.96 89.36 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.966 0.906 . . . . 0.0 112.861 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -53.98 -42.95 69.55 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.572 1.549 . . . . 0.0 113.056 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.58 -47.93 83.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.287 1.035 . . . . 0.0 112.156 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.09 -51.75 68.7 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.915 -0.491 . . . . 0.0 111.65 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -54.86 -39.51 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.547 1.539 . . . . 0.0 111.276 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -48.84 80.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.186 0.995 . . . . 0.0 111.989 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.3 mt -65.13 -53.82 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 110.977 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -69.28 -34.04 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.62 90.42 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.701 1.619 . . . . 0.0 112.897 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -49.32 59.82 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.273 1.037 . . . . 0.0 111.049 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -58.05 9.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.062 1.745 . . . . 0.0 113.371 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.61 -41.9 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.554 1.142 . . . . 0.0 111.228 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.94 -31.22 71.65 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.218 0.913 . . . . 0.0 113.569 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -37.58 61.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.663 1.232 . . . . 0.0 112.097 175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.3 mmm-85 -59.43 -41.16 88.94 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.061 1.344 . . . . 0.0 111.88 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.68 -50.13 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.994 1.718 . . . . 0.0 110.095 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.8 -40.58 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.738 . . . . 0.0 111.701 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -61.58 -38.32 87.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.358 1.063 . . . . 0.0 112.468 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.55 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.425 0.69 . . . . 0.0 111.349 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.1 -42.3 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.607 1.163 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.84 -39.88 95.72 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.747 -1.221 . . . . 0.0 112.302 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.27 -51.44 60.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.268 1.027 . . . . 0.0 112.136 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.8 -34.4 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.289 -0.882 . . . . 0.0 112.546 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -56.33 -31.76 64.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.978 1.311 . . . . 0.0 113.585 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -76.1 -13.64 60.2 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.807 1.243 . . . . 0.0 113.779 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 pttt . . . . . 0 C--O 1.253 1.271 0 C-N-CA 125.539 1.536 . . . . 0.0 112.964 177.484 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -51.44 -37.3 47.97 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 120.305 1.411 . . . . 0.0 114.155 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -52.69 -43.46 65.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.497 1.519 . . . . 0.0 113.032 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -64.6 -46.52 82.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 111.509 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -56.59 -50.75 71.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.999 0.519 . . . . 0.0 111.472 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.21 -42.82 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.443 1.097 . . . . 0.0 111.07 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.84 -44.81 93.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.41 1.005 . . . . 0.0 112.815 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.96 -53.78 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.857 0.863 . . . . 0.0 111.159 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.0 m -69.39 -24.78 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.64 -31.18 66.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.39 1.472 . . . . 0.0 113.54 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.25 75.79 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.391 1.095 . . . . 0.0 111.734 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -54.28 48.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.421 1.488 . . . . 0.0 112.992 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -64.88 -40.17 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 111.476 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.15 -31.79 56.51 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.836 1.207 . . . . 0.0 113.918 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.11 -40.34 70.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.511 1.156 . . . . 0.0 112.502 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -61.01 -38.69 86.98 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.94 0.791 . . . . 0.0 112.55 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.0 mt -68.4 -51.52 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.92 1.288 . . . . 0.0 109.866 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.93 -41.56 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.829 0.852 . . . . 0.0 111.78 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.89 -40.61 96.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.851 0.86 . . . . 0.0 112.685 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.83 91.75 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.734 -0.604 . . . . 0.0 111.673 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.73 -42.38 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.792 0.837 . . . . 0.0 111.962 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.01 -33.97 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.527 -1.358 . . . . 0.0 113.371 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -72.34 -50.94 23.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.095 0.958 . . . . 0.0 111.782 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.62 -31.69 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.244 -0.91 . . . . 0.0 112.951 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -58.52 -30.89 67.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.921 -1.112 . . . . 0.0 113.721 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -71.5 -21.43 61.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.254 1.331 0 CA-C-O 117.251 -1.357 . . . . 0.0 113.571 -178.477 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.1 mptt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 119.69 -0.195 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -55.6 -51.16 68.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.566 1.546 . . . . 0.0 112.717 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -52.33 -53.79 39.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.268 1.427 . . . . 0.0 111.862 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.96 -45.99 89.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.45 1.5 . . . . 0.0 112.032 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -55.25 -50.09 70.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.376 0.671 . . . . 0.0 111.504 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mt -58.16 -38.15 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.678 1.191 . . . . 0.0 111.315 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.9 mtp -64.98 -43.5 92.4 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.476 1.035 . . . . 0.0 112.643 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.26 -53.71 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.971 0.908 . . . . 0.0 110.723 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.03 -26.84 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.4 -37.0 79.45 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.567 1.556 . . . . 0.0 113.022 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.97 -51.87 55.87 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.671 0.736 . . . . 0.0 111.404 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.85 -53.45 52.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.177 1.791 . . . . 0.0 113.348 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.8 -45.01 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.68 91.76 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.23 0.919 . . . . 0.0 112.75 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -35.96 73.09 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.542 1.137 . . . . 0.0 113.145 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -57.87 -42.95 85.61 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 112.285 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.59 -50.81 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.461 1.505 . . . . 0.0 109.446 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.2 -45.23 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.303 1.041 . . . . 0.0 112.04 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.09 -42.97 91.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 112.482 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.53 79.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.171 0.589 . . . . 0.0 111.493 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.94 -41.89 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.154 0.582 . . . . 0.0 112.112 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.32 -44.21 95.66 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 t -63.88 -51.5 64.26 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.755 0.822 . . . . 0.0 111.791 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.8 tt -63.45 -30.85 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.292 -0.88 . . . . 0.0 112.643 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -40.86 97.89 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.411 1.084 . . . . 0.0 112.036 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -71.02 -22.87 62.1 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.066 1.346 . . . . 0.0 113.723 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 pttt . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.152 -178.233 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.9 tttt . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -46.36 -37.35 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.247 2.219 . . . . 0.0 114.675 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -51.54 -39.77 58.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.205 1.802 . . . . 0.0 113.742 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.04 -31.53 71.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.414 1.086 . . . . 0.0 112.474 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -66.01 -50.77 63.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.497 0.665 . . . . 0.0 110.486 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.7 mt -62.07 -35.86 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.578 1.551 . . . . 0.0 110.851 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -56.35 -39.47 72.9 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.711 1.204 . . . . 0.0 112.516 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.9 mt -68.92 -53.85 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.377 1.071 . . . . 0.0 110.597 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.96 -29.6 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.392 0.677 . . . . 0.0 112.727 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.09 67.6 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.849 1.214 . . . . 0.0 114.284 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.54 -52.06 37.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.708 1.254 . . . . 0.0 111.849 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -52.69 64.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.498 1.519 . . . . 0.0 112.9 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.45 -41.54 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.697 1.199 . . . . 0.0 111.609 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.46 -44.21 95.46 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.366 0.984 . . . . 0.0 112.643 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -45.72 74.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.196 0.998 . . . . 0.0 112.089 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -56.56 -45.57 81.21 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.579 1.152 . . . . 0.0 112.984 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -64.44 -51.14 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.553 1.141 . . . . 0.0 109.63 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.49 -42.2 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.527 1.131 . . . . 0.0 111.869 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.52 -44.14 97.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.716 1.606 . . . . 0.0 112.692 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -45.58 88.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.131 0.573 . . . . 0.0 111.612 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.47 -40.48 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.373 1.069 . . . . 0.0 111.8 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.34 -43.45 98.79 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.668 -1.27 . . . . 0.0 112.481 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.5 m -63.94 -51.16 65.72 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.188 0.995 . . . . 0.0 112.16 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.48 -31.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.845 0.748 . . . . 0.0 112.43 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.26 -40.43 95.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.438 1.017 . . . . 0.0 112.505 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.78 -14.71 60.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.485 1.293 0 C-N-CA 126.522 1.929 . . . . 0.0 113.221 -179.418 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.018 -0.039 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -60.42 -37.64 81.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.213 1.005 . . . . 0.0 113.215 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -57.13 -44.79 83.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.308 1.043 . . . . 0.0 112.112 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -44.77 95.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.683 1.193 . . . . 0.0 111.696 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.57 -51.53 69.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.271 0.487 . . . . 0.0 111.761 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.93 -39.82 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.875 1.27 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.81 -47.55 85.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.238 0.926 . . . . 0.0 112.609 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.61 -53.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.0 0.92 . . . . 0.0 110.783 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.8 m -66.36 -38.68 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.144 0.578 . . . . 0.0 112.255 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.83 -32.59 84.69 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.336 1.446 . . . . 0.0 113.38 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.21 -53.27 41.02 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.374 1.087 . . . . 0.0 112.078 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.45 46.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.983 1.313 . . . . 0.0 113.159 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.6 -32.96 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.11 0.964 . . . . 0.0 111.677 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.38 -40.74 23.51 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.935 1.731 . . . . 0.0 113.537 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -39.5 79.38 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.133 0.973 . . . . 0.0 112.483 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -62.94 -40.31 97.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.279 1.032 . . . . 0.0 112.21 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.85 -45.31 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.921 1.288 . . . . 0.0 110.228 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -56.19 -40.5 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.017 0.927 . . . . 0.0 111.551 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -43.96 98.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.749 0.819 . . . . 0.0 112.613 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.76 90.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.729 0.811 . . . . 0.0 111.925 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.8 -40.64 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.966 0.906 . . . . 0.0 111.825 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.95 -42.86 99.59 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.872 -1.142 . . . . 0.0 112.041 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.0 t -63.16 -51.48 66.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.404 0.682 . . . . 0.0 112.066 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tt -66.22 -26.45 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.359 -0.838 . . . . 0.0 112.687 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -66.05 -39.58 90.23 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.92 -1.112 . . . . 0.0 112.763 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.88 -28.46 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.122 0.969 . . . . 0.0 112.362 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 pttt . . . . . 0 C--O 1.253 1.279 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.178 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.6 mttp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.675 -0.203 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -59.71 -33.66 71.9 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -54.72 -44.04 73.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.465 1.106 . . . . 0.0 112.97 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.62 -45.27 91.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.483 1.113 . . . . 0.0 111.816 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.92 -50.95 71.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.031 0.532 . . . . 0.0 111.784 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.86 -40.29 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.654 1.582 . . . . 0.0 111.152 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.29 -42.0 98.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.346 0.975 . . . . 0.0 113.485 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.99 -53.84 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.02 0.827 . . . . 0.0 110.612 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.81 -30.67 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.93 -30.78 70.54 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.795 1.664 . . . . 0.0 113.762 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.81 -56.92 6.18 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.172 0.986 . . . . 0.0 110.945 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -56.33 23.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.788 1.635 . . . . 0.0 113.478 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.1 -41.94 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.105 1.362 . . . . 0.0 110.776 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.09 62.74 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.4 1.0 . . . . 0.0 112.727 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -42.81 68.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.56 1.144 . . . . 0.0 112.998 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -40.52 97.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.148 0.979 . . . . 0.0 112.131 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.15 -48.01 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.198 0.999 . . . . 0.0 109.838 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -55.67 -44.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.458 0.703 . . . . 0.0 111.651 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -44.43 97.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.346 0.659 . . . . 0.0 112.327 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.64 91.2 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.725 0.81 . . . . 0.0 112.496 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.43 -42.43 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.701 0.8 . . . . 0.0 111.406 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -58.22 -44.41 88.17 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.15 -0.969 . . . . 0.0 112.082 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -64.55 -51.51 62.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.733 0.813 . . . . 0.0 112.547 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.1 -30.34 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.2 -0.937 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -42.04 95.37 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.647 1.179 . . . . 0.0 112.203 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -72.05 -21.36 61.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.703 1.601 . . . . 0.0 113.621 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.574 1.95 . . . . 0.0 113.434 -169.354 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.9 mttt . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -40.73 11.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.583 1.953 . . . . 0.0 115.111 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -58.15 -38.45 76.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.122 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.31 -42.14 72.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.071 0.948 . . . . 0.0 111.365 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.89 -51.42 69.71 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.329 0.513 . . . . 0.0 111.365 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.0 mt -55.72 -43.11 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.98 1.312 . . . . 0.0 111.211 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -58.27 -46.57 85.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.777 0.831 . . . . 0.0 112.494 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.18 -53.82 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.0 0.92 . . . . 0.0 111.106 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.37 -24.14 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.3 -22.89 51.99 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.795 1.664 . . . . 0.0 113.514 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.96 -57.96 4.62 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.417 1.108 . . . . 0.0 110.37 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -54.0 34.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.642 1.577 . . . . 0.0 113.744 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.35 -49.7 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.091 1.356 . . . . 0.0 110.836 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.79 -24.39 53.44 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.8 0.714 . . . . 0.0 113.989 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -31.86 62.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.43 1.092 . . . . 0.0 111.638 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -57.51 -35.9 70.86 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.4 1.0 . . . . 0.0 113.355 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.21 -49.22 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.699 1.6 . . . . 0.0 109.383 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.67 -40.12 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.143 0.977 . . . . 0.0 111.893 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.59 -45.32 94.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.207 1.003 . . . . 0.0 112.031 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.65 93.43 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 0.0 111.997 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.0 -41.25 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.168 0.987 . . . . 0.0 111.669 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.98 -41.36 97.93 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.825 -1.172 . . . . 0.0 112.427 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 m -64.85 -51.51 61.65 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.67 0.788 . . . . 0.0 112.386 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -64.7 -32.42 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.108 0.867 . . . . 0.0 112.467 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.66 -32.47 63.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.067 1.347 . . . . 0.0 113.17 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -13.72 60.41 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.028 1.731 . . . . 0.0 112.1 -177.662 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.159 0.028 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -60.59 -43.0 97.87 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 0.0 112.747 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -54.8 -45.98 74.42 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.538 1.135 . . . . 0.0 112.358 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.84 -42.92 84.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.13 1.372 . . . . 0.0 112.329 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -58.15 -53.01 63.15 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.451 0.569 . . . . 0.0 111.392 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -56.06 -40.84 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.806 1.642 . . . . 0.0 110.94 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.8 mmm -57.2 -47.83 80.29 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.09 0.956 . . . . 0.0 112.335 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.02 -53.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.811 0.844 . . . . 0.0 111.284 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.12 -30.42 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.49 -19.63 71.0 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.724 1.63 . . . . 0.0 113.675 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.71 -50.16 20.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.01 1.405 . . . . 0.0 110.559 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -57.79 11.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.024 1.73 . . . . 0.0 112.803 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.23 -32.99 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.64 0.776 . . . . 0.0 111.438 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.24 -34.16 53.2 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.44 1.495 . . . . 0.0 113.949 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -42.1 70.96 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.064 1.432 . . . . 0.0 111.946 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -62.02 -39.13 91.24 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.739 1.216 . . . . 0.0 112.049 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.39 -51.95 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.444 1.497 . . . . 0.0 110.34 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -56.78 -40.81 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.371 1.468 . . . . 0.0 111.672 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.99 -43.8 98.34 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.984 0.914 . . . . 0.0 112.332 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.08 92.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.5 -40.37 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.003 0.921 . . . . 0.0 111.824 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.6 mt -62.91 -43.54 98.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.011 -1.056 . . . . 0.0 111.607 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -64.4 -49.06 73.05 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.568 0.747 . . . . 0.0 112.173 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.24 -34.21 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.8 0.727 . . . . 0.0 112.583 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.41 -31.45 65.85 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.305 1.442 . . . . 0.0 113.939 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -77.03 -10.8 59.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.162 1.385 . . . . 0.0 113.655 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.565 1.546 . . . . 0.0 113.07 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -47.32 -48.77 25.1 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.083 1.753 . . . . 0.0 113.377 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -55.31 -50.21 70.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.202 1.401 . . . . 0.0 112.792 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.63 -43.52 98.71 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 111.336 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -56.31 -47.73 78.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.714 0.688 . . . . 0.0 111.903 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.05 -40.25 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 111.312 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 mtp -64.67 -41.12 96.3 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.251 -0.906 . . . . 0.0 113.186 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -62.12 -53.66 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.247 1.019 . . . . 0.0 110.768 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.81 -29.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.82 93.48 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.683 1.135 . . . . 0.0 112.9 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.55 89.85 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.078 0.939 . . . . 0.0 112.149 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -55.61 32.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.315 1.446 . . . . 0.0 112.89 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.3 -38.25 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.672 0.789 . . . . 0.0 111.576 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.15 -23.47 12.34 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.585 1.564 . . . . 0.0 115.052 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -35.17 64.25 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.639 1.22 . . . . 0.0 111.713 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -36.55 74.57 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.562 1.073 . . . . 0.0 113.252 175.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.29 -50.2 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.282 1.433 . . . . 0.0 109.188 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -58.14 -42.11 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.801 0.84 . . . . 0.0 111.627 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -44.63 93.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.001 0.92 . . . . 0.0 112.28 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -36.62 80.57 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.862 0.865 . . . . 0.0 112.689 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.34 -40.02 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.115 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.31 -44.86 95.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.877 -1.139 . . . . 0.0 112.418 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -66.08 -47.6 73.71 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.771 0.714 . . . . 0.0 112.827 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.18 -33.07 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.356 0.98 . . . . 0.0 112.453 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -62.37 -39.01 91.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.004 0.922 . . . . 0.0 111.856 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -74.71 -19.64 60.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.715 1.206 . . . . 0.0 113.157 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.251 1.42 . . . . 0.0 112.077 172.592 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -60.51 -37.14 80.18 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 119.683 -1.886 . . . . 0.0 113.506 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -55.22 -42.94 74.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.838 1.255 . . . . 0.0 112.997 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.61 -42.69 91.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 111.55 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -60.22 -49.15 78.75 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.678 0.791 . . . . 0.0 112.14 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -55.01 -45.0 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.265 1.426 . . . . 0.0 111.03 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.5 mmm -56.56 -42.93 79.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.194 0.998 . . . . 0.0 112.905 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.68 -53.8 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.05 0.94 . . . . 0.0 111.252 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.27 -26.98 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.82 -30.41 66.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.43 1.014 . . . . 0.0 113.471 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.81 -51.65 33.86 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.308 1.054 . . . . 0.0 111.737 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.48 -55.28 30.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.884 1.673 . . . . 0.0 112.793 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.08 -38.66 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.238 1.015 . . . . 0.0 111.578 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.94 -44.53 96.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.156 0.884 . . . . 0.0 112.971 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -37.02 71.38 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.13 0.972 . . . . 0.0 112.272 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -57.23 -40.95 78.6 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.436 1.095 . . . . 0.0 112.476 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.54 -51.95 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.234 1.414 . . . . 0.0 109.809 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -58.56 -41.46 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.748 0.819 . . . . 0.0 112.08 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.53 -42.43 96.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.73 1.212 . . . . 0.0 112.649 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.96 92.15 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.628 0.771 . . . . 0.0 111.875 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.33 -40.05 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.104 0.962 . . . . 0.0 111.716 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mt -60.85 -44.83 96.46 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.45 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 t -62.99 -51.58 66.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.915 0.886 . . . . 0.0 112.096 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -63.41 -33.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.319 -0.863 . . . . 0.0 112.518 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -61.98 -27.95 69.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.226 1.011 . . . . 0.0 113.036 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -14.36 50.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.576 1.55 . . . . 0.0 112.129 -177.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.336 -0.84 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -50.33 -33.41 20.16 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.435 1.471 . . . . 0.0 114.268 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -50.73 -43.37 58.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.238 1.815 . . . . 0.0 112.469 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 31.6 mt -69.47 -42.51 74.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.16 1.384 . . . . 0.0 111.544 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -56.54 -47.64 79.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.299 0.64 . . . . 0.0 111.605 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.6 mt -54.45 -43.22 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.807 1.243 . . . . 0.0 111.339 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtm -60.84 -46.37 90.81 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.428 -0.795 . . . . 0.0 112.502 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.13 -53.68 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.308 1.043 . . . . 0.0 110.963 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 m -65.4 -29.8 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.74 87.38 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.869 1.224 . . . . 0.0 113.802 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.63 -46.5 93.6 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 118.323 1.061 . . . . 0.0 112.667 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -54.64 41.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.803 1.641 . . . . 0.0 112.722 175.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.81 -36.74 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 111.421 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.14 52.59 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 112.905 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -40.51 82.92 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.888 0.844 . . . . 0.0 111.864 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -46.41 76.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.221 1.409 . . . . 0.0 112.025 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -66.68 -49.57 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.991 1.317 . . . . 0.0 109.887 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.7 -49.28 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.096 0.958 . . . . 0.0 111.52 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.55 -44.82 93.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.676 0.79 . . . . 0.0 112.813 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.13 83.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.455 0.702 . . . . 0.0 112.614 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.85 -41.89 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.265 1.026 . . . . 0.0 111.413 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.1 -43.2 95.72 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.874 -1.141 . . . . 0.0 112.275 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m -63.39 -51.41 65.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.476 0.711 . . . . 0.0 112.851 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.1 tt -64.72 -33.05 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.242 0.928 . . . . 0.0 112.859 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -61.07 -42.48 98.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 0.0 112.178 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -74.35 -15.22 60.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.639 1.575 . . . . 0.0 114.828 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 126.679 1.992 . . . . 0.0 113.181 -173.546 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -55.44 -49.12 73.27 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.224 1.81 . . . . 0.0 113.2 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -57.2 -46.16 83.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.122 0.969 . . . . 0.0 112.907 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.15 -42.79 95.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.516 1.126 . . . . 0.0 112.113 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -58.31 -49.93 75.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.647 0.658 . . . . 0.0 111.647 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.38 -40.01 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.572 1.149 . . . . 0.0 111.527 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.5 mmt -59.33 -42.17 90.84 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.479 1.036 . . . . 0.0 112.843 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.29 -53.57 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.389 0.676 . . . . 0.0 111.013 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.21 -35.42 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.57 82.83 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.564 1.554 . . . . 0.0 112.616 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.28 58.22 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -54.19 47.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.926 1.691 . . . . 0.0 113.635 176.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.12 -44.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.436 0.694 . . . . 0.0 111.245 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.45 -35.46 85.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.604 1.097 . . . . 0.0 113.491 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -41.01 68.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.973 1.309 . . . . 0.0 112.22 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.56 1.144 . . . . 0.0 111.904 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.48 -51.59 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.92 1.688 . . . . 0.0 110.122 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.16 -41.97 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.892 1.277 . . . . 0.0 111.666 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -45.05 95.3 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.773 1.229 . . . . 0.0 112.344 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.05 -45.69 90.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.421 0.688 . . . . 0.0 112.055 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.75 -42.6 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.73 1.212 . . . . 0.0 111.393 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.3 -43.84 95.93 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.91 -1.119 . . . . 0.0 111.788 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.5 m -64.05 -50.77 67.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 112.681 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.73 -30.86 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.044 0.838 . . . . 0.0 112.614 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -61.14 -43.19 99.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.562 1.145 . . . . 0.0 111.636 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -73.8 -17.61 61.06 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 0.0 113.924 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.795 2.038 . . . . 0.0 112.885 -177.308 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.266 0.079 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.75 -47.46 84.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.945 1.298 . . . . 0.0 112.794 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -56.5 -45.79 80.86 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.937 1.295 . . . . 0.0 112.241 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.81 -43.47 96.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.788 1.235 . . . . 0.0 111.569 175.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -57.42 -49.8 75.05 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.578 -0.701 . . . . 0.0 111.775 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mt -58.38 -39.12 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.894 1.278 . . . . 0.0 111.056 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmm -61.3 -43.59 98.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.663 0.785 . . . . 0.0 112.291 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.85 -53.58 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.794 0.838 . . . . 0.0 111.07 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.8 -38.21 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.979 0.511 . . . . 0.0 112.231 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.38 91.37 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.43 1.49 . . . . 0.0 112.915 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -47.87 84.98 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.179 0.99 . . . . 0.0 111.862 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -56.81 17.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.328 1.051 . . . . 0.0 113.093 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.25 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.855 0.862 . . . . 0.0 111.674 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.41 -26.91 57.49 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.221 1.391 . . . . 0.0 114.121 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -40.06 72.65 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.62 1.21 . . . . 0.0 111.47 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -60.0 -38.54 82.95 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.404 -0.81 . . . . 0.0 112.532 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm -68.28 -50.32 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.729 1.211 . . . . 0.0 110.133 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.65 -42.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.146 0.978 . . . . 0.0 111.848 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.37 -40.93 96.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.818 0.847 . . . . 0.0 112.296 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.37 97.43 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.802 -0.561 . . . . 0.0 111.221 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.71 -40.33 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.518 0.727 . . . . 0.0 112.16 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.45 -41.95 99.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.955 -1.091 . . . . 0.0 112.183 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t -67.1 -50.46 61.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 0.0 112.38 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.44 -33.32 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.099 -1.0 . . . . 0.0 112.54 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -58.34 -34.12 70.29 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.649 1.18 . . . . 0.0 113.729 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -74.02 -15.39 61.09 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.271 1.428 . . . . 0.0 113.688 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.33 1.852 . . . . 0.0 111.371 -173.816 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.668 0.747 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -69.42 -36.94 77.19 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.809 -1.182 . . . . 0.0 112.479 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -55.95 -45.56 78.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.86 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.93 -44.56 96.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.934 0.894 . . . . 0.0 111.931 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.26 -51.01 71.08 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.198 0.454 . . . . 0.0 111.611 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.86 -40.52 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.723 1.209 . . . . 0.0 111.116 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmt -60.8 -46.13 91.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.028 0.831 . . . . 0.0 112.519 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.16 -53.69 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.899 0.879 . . . . 0.0 111.155 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.17 -29.19 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.26 -31.85 78.59 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.482 1.515 . . . . 0.0 113.277 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.18 -43.41 80.49 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.408 1.104 . . . . 0.0 111.955 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -55.99 26.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.0 -37.66 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.581 0.752 . . . . 0.0 111.281 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.9 -34.73 38.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.91 1.719 . . . . 0.0 114.142 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.16 -33.86 63.31 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.255 1.022 . . . . 0.0 112.529 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -58.94 -43.33 91.21 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.431 1.014 . . . . 0.0 112.275 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.78 -49.68 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.312 1.045 . . . . 0.0 110.769 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.16 -43.15 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.636 0.774 . . . . 0.0 111.558 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.94 -41.01 95.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.301 1.04 . . . . 0.0 111.956 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.66 79.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.447 0.699 . . . . 0.0 111.709 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.5 -41.35 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 111.613 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.09 -42.51 98.64 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.963 -1.086 . . . . 0.0 112.707 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 m -66.67 -51.42 56.26 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.579 0.752 . . . . 0.0 112.274 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.82 -33.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 119.48 1.036 . . . . 0.0 112.519 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -56.58 -34.03 66.76 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.115 0.966 . . . . 0.0 112.648 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.0 -15.23 58.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.7 pttt . . . . . 0 C--O 1.254 1.297 0 CA-C-O 117.069 -1.443 . . . . 0.0 113.749 -176.056 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -60.75 -34.83 75.02 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.107 1.321 . . . . 0.0 114.345 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -56.61 -47.16 80.23 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.337 1.055 . . . . 0.0 112.575 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.16 -42.35 94.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.573 1.149 . . . . 0.0 111.979 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.2 -48.77 77.96 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.472 0.578 . . . . 0.0 111.412 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.73 -38.99 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.075 1.35 . . . . 0.0 111.266 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.4 mtt -59.81 -41.54 91.48 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.389 0.995 . . . . 0.0 112.39 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.97 -53.78 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.13 0.972 . . . . 0.0 110.69 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.69 -26.22 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.0 -27.72 62.69 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.543 1.544 . . . . 0.0 113.97 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 -52.61 30.15 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 118.469 1.134 . . . . 0.0 111.187 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -55.0 39.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.399 1.479 . . . . 0.0 113.369 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.06 -31.14 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.839 0.856 . . . . 0.0 111.531 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.12 -36.13 27.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.652 1.596 . . . . 0.0 113.911 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -37.98 76.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.423 1.111 . . . . 0.0 113.023 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -62.44 -45.4 93.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.345 1.058 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 mt -64.07 -47.23 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.23 1.412 . . . . 0.0 109.564 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.77 -41.94 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.36 1.064 . . . . 0.0 111.901 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -45.96 92.04 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.756 0.822 . . . . 0.0 112.356 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 -44.18 94.11 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.796 0.838 . . . . 0.0 112.274 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.72 -41.59 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.285 1.034 . . . . 0.0 111.486 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.64 -42.07 98.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.974 -1.079 . . . . 0.0 112.217 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.7 m -64.7 -49.29 71.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.778 0.831 . . . . 0.0 112.584 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.05 -30.79 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.219 0.918 . . . . 0.0 112.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -60.71 -28.04 68.35 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.388 1.075 . . . . 0.0 113.844 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -78.07 -15.12 59.18 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.29 1.436 . . . . 0.0 113.639 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.585 1.554 . . . . 0.0 112.428 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -51.34 -32.37 25.23 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.998 1.719 . . . . 0.0 115.617 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -56.78 -37.23 70.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.161 1.384 . . . . 0.0 112.906 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.62 -45.21 72.49 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.104 1.362 . . . . 0.0 111.448 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.38 -52.2 66.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.126 0.57 . . . . 0.0 111.889 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -39.85 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.282 1.433 . . . . 0.0 110.795 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 mmm -59.73 -51.39 69.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.915 . . . . 0.0 111.977 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.84 -51.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.595 0.758 . . . . 0.0 111.368 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 m -67.85 -37.55 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.157 0.583 . . . . 0.0 111.977 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.77 99.52 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.545 1.545 . . . . 0.0 112.811 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.17 -45.82 93.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 117.949 0.874 . . . . 0.0 111.913 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -51.71 67.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.903 1.281 . . . . 0.0 112.871 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.47 -44.47 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.066 0.546 . . . . 0.0 111.777 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.77 64.83 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.296 0.951 . . . . 0.0 114.162 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -40.18 67.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.672 1.236 . . . . 0.0 111.886 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -58.88 -36.95 75.49 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.787 1.235 . . . . 0.0 111.875 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.85 -50.03 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.551 1.541 . . . . 0.0 110.692 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.63 -44.91 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.963 0.905 . . . . 0.0 111.722 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.8 -37.82 85.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.983 0.913 . . . . 0.0 112.478 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.28 86.12 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.545 0.611 . . . . 0.0 111.471 174.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' HG22 ' A' ' 24' ' ' ILE . 43.3 t -66.38 -41.81 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.287 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.54 -42.28 96.22 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.891 -1.131 . . . . 0.0 112.544 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -66.87 -49.51 65.42 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.292 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.413 HG22 ' HA ' ' A' ' 21' ' ' VAL . 13.6 tt -63.32 -35.75 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.583 1.083 . . . . 0.0 112.454 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -35.74 69.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.554 1.141 . . . . 0.0 111.996 174.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.53 -11.52 59.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.108 1.763 . . . . 0.0 114.253 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 116.992 -1.48 . . . . 0.0 113.243 -178.49 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.9 pttp . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -54.93 -30.56 58.89 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 121.152 1.796 . . . . 0.0 115.468 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -53.01 -44.73 67.5 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.577 1.551 . . . . 0.0 111.718 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.96 -45.21 86.66 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.791 1.236 . . . . 0.0 111.432 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.11 -52.85 63.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 111.244 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.38 -42.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.977 1.311 . . . . 0.0 111.151 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -46.45 80.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.237 1.015 . . . . 0.0 112.475 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.05 -53.9 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.23 1.012 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.1 -27.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.93 -25.52 64.18 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.735 1.636 . . . . 0.0 113.819 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.02 -54.04 15.93 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.636 1.218 . . . . 0.0 110.589 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -54.67 43.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.636 1.574 . . . . 0.0 113.287 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.47 -35.47 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.38 1.072 . . . . 0.0 111.475 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.94 96.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.041 0.829 . . . . 0.0 112.252 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -44.36 66.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.899 1.279 . . . . 0.0 112.106 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -43.57 76.33 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.949 1.3 . . . . 0.0 112.55 175.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.82 -47.69 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.847 1.259 . . . . 0.0 109.903 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.7 -40.01 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.758 -0.589 . . . . 0.0 112.023 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -42.24 92.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.264 1.026 . . . . 0.0 112.333 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.96 87.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.726 0.81 . . . . 0.0 111.854 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.7 -41.96 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 111.901 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.7 -40.59 95.58 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.017 -1.052 . . . . 0.0 112.385 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -66.62 -51.53 55.27 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.762 0.825 . . . . 0.0 112.101 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 tt -63.72 -32.43 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.391 -0.818 . . . . 0.0 112.61 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -56.97 -36.79 70.73 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.394 1.477 . . . . 0.0 113.372 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -11.85 58.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.224 1.41 . . . . 0.0 113.556 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.275 0 C-N-CA 127.364 2.266 . . . . 0.0 112.866 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -49.93 -36.53 28.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 125.843 1.657 . . . . 0.0 114.702 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -54.31 -38.73 66.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.959 1.304 . . . . 0.0 113.676 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.17 -39.61 71.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.279 1.032 . . . . 0.0 111.951 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.18 -48.83 79.09 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.426 0.557 . . . . 0.0 111.463 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.5 mt -57.94 -39.71 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.004 1.321 . . . . 0.0 110.978 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.03 -38.3 88.18 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.27 -0.894 . . . . 0.0 113.395 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.9 mt -65.31 -53.86 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.009 0.924 . . . . 0.0 110.459 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.33 -22.07 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.56 -26.22 59.42 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.869 1.7 . . . . 0.0 114.402 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.9 8.66 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.673 1.236 . . . . 0.0 111.232 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -57.3 9.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.765 1.626 . . . . 0.0 113.381 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.79 -34.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.76 -26.86 58.31 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.521 1.058 . . . . 0.0 114.215 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -41.22 76.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.924 1.362 . . . . 0.0 111.534 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -59.8 -44.08 94.16 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.853 0.861 . . . . 0.0 112.629 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.3 mt -65.64 -51.82 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.213 1.405 . . . . 0.0 109.566 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.32 -43.12 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.922 1.289 . . . . 0.0 111.752 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.32 -42.65 99.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.303 1.041 . . . . 0.0 112.353 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.1 97.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.525 -0.734 . . . . 0.0 111.715 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.07 -35.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.588 1.155 . . . . 0.0 111.716 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.0 -45.23 78.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.673 -1.267 . . . . 0.0 110.754 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 m -62.72 -47.43 83.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.386 1.074 . . . . 0.0 112.472 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 tt -66.82 -35.75 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 118.962 0.801 . . . . 0.0 112.571 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -59.87 -24.48 64.28 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.087 1.312 . . . . 0.0 113.461 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -71.11 -30.25 66.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.99 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -160.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -54.78 -46.32 74.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.698 1.599 . . . . 0.0 112.968 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.76 -45.12 91.24 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.932 0.893 . . . . 0.0 111.87 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.06 -50.08 74.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.385 0.539 . . . . 0.0 111.763 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -58.08 -37.32 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.213 1.405 . . . . 0.0 110.852 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.6 mtt -61.95 -44.32 97.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.83 1.196 . . . . 0.0 112.228 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.46 -53.71 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.025 0.93 . . . . 0.0 110.729 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.38 -27.98 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.23 -40.61 99.25 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.532 1.539 . . . . 0.0 112.989 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.16 94.35 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 118.04 0.92 . . . . 0.0 112.256 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 125.552 1.541 . . . . 0.0 112.233 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.75 -44.58 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.055 0.942 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.5 -45.79 92.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.495 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.4 81.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.363 0.665 . . . . 0.0 112.104 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.18 -39.97 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.072 0.949 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.24 -42.64 99.24 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.798 -1.189 . . . . 0.0 111.992 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -63.26 -51.53 65.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 112.193 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -64.41 -31.63 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.308 -0.87 . . . . 0.0 112.653 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -34.85 76.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.827 1.251 . . . . 0.0 112.561 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 124.259 1.024 . . . . 0.0 112.659 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -52.66 -41.32 63.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.929 1.291 . . . . 0.0 113.003 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.83 -47.7 65.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.111 1.764 . . . . 0.0 111.651 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.79 -49.33 76.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.388 0.54 . . . . 0.0 111.96 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.37 -37.11 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 111.167 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -43.33 97.5 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.426 1.012 . . . . 0.0 112.801 175.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.85 -53.67 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.481 0.712 . . . . 0.0 110.846 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.99 -34.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.018 0.527 . . . . 0.0 112.4 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.53 77.48 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.426 1.489 . . . . 0.0 113.838 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.85 -56.59 12.16 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.058 0.929 . . . . 0.0 111.6 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 125.397 1.479 . . . . 0.0 113.629 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -57.44 -40.35 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.858 0.863 . . . . 0.0 111.954 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -43.24 91.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.137 0.975 . . . . 0.0 112.277 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.56 84.86 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.794 0.838 . . . . 0.0 111.591 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.97 -41.16 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.83 -43.43 94.58 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.905 -1.122 . . . . 0.0 112.007 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 t -67.32 -48.14 68.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.589 0.756 . . . . 0.0 112.394 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.9 tt -64.15 -31.86 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.372 -0.83 . . . . 0.0 112.453 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -61.49 -40.51 94.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.27 0.941 . . . . 0.0 112.531 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.5 mttt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 175.101 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -53.98 -42.95 69.55 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.572 1.549 . . . . 0.0 113.056 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.58 -47.93 83.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.287 1.035 . . . . 0.0 112.156 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.09 -51.75 68.7 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.915 -0.491 . . . . 0.0 111.65 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -54.86 -39.51 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.547 1.539 . . . . 0.0 111.276 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -48.84 80.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.186 0.995 . . . . 0.0 111.989 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.3 mt -65.13 -53.82 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 110.977 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -69.28 -34.04 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.62 90.42 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.701 1.619 . . . . 0.0 112.897 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -49.32 59.82 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.273 1.037 . . . . 0.0 111.049 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 126.062 1.745 . . . . 0.0 113.371 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.8 -40.58 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.738 . . . . 0.0 111.701 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -61.58 -38.32 87.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.358 1.063 . . . . 0.0 112.468 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.55 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.425 0.69 . . . . 0.0 111.349 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.1 -42.3 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.607 1.163 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.84 -39.88 95.72 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.747 -1.221 . . . . 0.0 112.302 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.27 -51.44 60.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.268 1.027 . . . . 0.0 112.136 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.8 -34.4 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.289 -0.882 . . . . 0.0 112.546 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -56.33 -31.76 64.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.978 1.311 . . . . 0.0 113.585 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.9 tttm . . . . . 0 N--CA 1.474 0.764 0 C-N-CA 124.807 1.243 . . . . 0.0 113.779 177.742 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tptm . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -52.69 -43.46 65.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.497 1.519 . . . . 0.0 113.032 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -64.6 -46.52 82.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 111.509 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -56.59 -50.75 71.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.999 0.519 . . . . 0.0 111.472 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.21 -42.82 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.443 1.097 . . . . 0.0 111.07 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.84 -44.81 93.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.41 1.005 . . . . 0.0 112.815 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.96 -53.78 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.857 0.863 . . . . 0.0 111.159 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.0 m -69.39 -24.78 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.64 -31.18 66.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.39 1.472 . . . . 0.0 113.54 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.25 75.79 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.391 1.095 . . . . 0.0 111.734 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 125.421 1.488 . . . . 0.0 112.992 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.93 -41.56 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.829 0.852 . . . . 0.0 111.78 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.89 -40.61 96.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.851 0.86 . . . . 0.0 112.685 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.83 91.75 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.734 -0.604 . . . . 0.0 111.673 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.73 -42.38 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.792 0.837 . . . . 0.0 111.962 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.01 -33.97 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.527 -1.358 . . . . 0.0 113.371 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -72.34 -50.94 23.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.095 0.958 . . . . 0.0 111.782 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.62 -31.69 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.244 -0.91 . . . . 0.0 112.951 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -58.52 -30.89 67.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.921 -1.112 . . . . 0.0 113.721 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mttp . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 175.079 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -52.33 -53.79 39.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.268 1.427 . . . . 0.0 111.862 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.96 -45.99 89.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.45 1.5 . . . . 0.0 112.032 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -55.25 -50.09 70.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.376 0.671 . . . . 0.0 111.504 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mt -58.16 -38.15 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.678 1.191 . . . . 0.0 111.315 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.9 mtp -64.98 -43.5 92.4 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.476 1.035 . . . . 0.0 112.643 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.26 -53.71 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.971 0.908 . . . . 0.0 110.723 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.03 -26.84 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.4 -37.0 79.45 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.567 1.556 . . . . 0.0 113.022 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.97 -51.87 55.87 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.671 0.736 . . . . 0.0 111.404 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 126.177 1.791 . . . . 0.0 113.348 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.2 -45.23 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.303 1.041 . . . . 0.0 112.04 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.09 -42.97 91.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 112.482 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.53 79.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.171 0.589 . . . . 0.0 111.493 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.94 -41.89 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.154 0.582 . . . . 0.0 112.112 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.32 -44.21 95.66 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 t -63.88 -51.5 64.26 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.755 0.822 . . . . 0.0 111.791 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.8 tt -63.45 -30.85 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.292 -0.88 . . . . 0.0 112.643 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -40.86 97.89 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.411 1.084 . . . . 0.0 112.036 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 125.066 1.346 . . . . 0.0 113.723 174.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -51.54 -39.77 58.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.205 1.802 . . . . 0.0 113.742 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.04 -31.53 71.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.414 1.086 . . . . 0.0 112.474 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -66.01 -50.77 63.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.497 0.665 . . . . 0.0 110.486 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.7 mt -62.07 -35.86 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.578 1.551 . . . . 0.0 110.851 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -56.35 -39.47 72.9 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.711 1.204 . . . . 0.0 112.516 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.9 mt -68.92 -53.85 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.377 1.071 . . . . 0.0 110.597 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.96 -29.6 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.392 0.677 . . . . 0.0 112.727 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.09 67.6 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.849 1.214 . . . . 0.0 114.284 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.54 -52.06 37.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.708 1.254 . . . . 0.0 111.849 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 125.498 1.519 . . . . 0.0 112.9 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.49 -42.2 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.527 1.131 . . . . 0.0 111.869 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.52 -44.14 97.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.716 1.606 . . . . 0.0 112.692 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -45.58 88.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.131 0.573 . . . . 0.0 111.612 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.47 -40.48 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.373 1.069 . . . . 0.0 111.8 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.34 -43.45 98.79 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.668 -1.27 . . . . 0.0 112.481 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.5 m -63.94 -51.16 65.72 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.188 0.995 . . . . 0.0 112.16 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.48 -31.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.845 0.748 . . . . 0.0 112.43 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.26 -40.43 95.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.438 1.017 . . . . 0.0 112.505 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptt . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 175.193 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -57.13 -44.79 83.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.308 1.043 . . . . 0.0 112.112 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -44.77 95.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.683 1.193 . . . . 0.0 111.696 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.57 -51.53 69.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.271 0.487 . . . . 0.0 111.761 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.93 -39.82 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.875 1.27 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.81 -47.55 85.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.238 0.926 . . . . 0.0 112.609 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.61 -53.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.0 0.92 . . . . 0.0 110.783 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.8 m -66.36 -38.68 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.144 0.578 . . . . 0.0 112.255 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.83 -32.59 84.69 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.336 1.446 . . . . 0.0 113.38 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.21 -53.27 41.02 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.374 1.087 . . . . 0.0 112.078 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.983 1.313 . . . . 0.0 113.159 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -56.19 -40.5 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.017 0.927 . . . . 0.0 111.551 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -43.96 98.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.749 0.819 . . . . 0.0 112.613 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.76 90.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.729 0.811 . . . . 0.0 111.925 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.8 -40.64 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.966 0.906 . . . . 0.0 111.825 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.95 -42.86 99.59 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.872 -1.142 . . . . 0.0 112.041 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.0 t -63.16 -51.48 66.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.404 0.682 . . . . 0.0 112.066 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tt -66.22 -26.45 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.359 -0.838 . . . . 0.0 112.687 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -66.05 -39.58 90.23 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.92 -1.112 . . . . 0.0 112.763 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.122 0.969 . . . . 0.0 112.362 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -54.72 -44.04 73.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.465 1.106 . . . . 0.0 112.97 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.62 -45.27 91.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.483 1.113 . . . . 0.0 111.816 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.92 -50.95 71.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.031 0.532 . . . . 0.0 111.784 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.86 -40.29 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.654 1.582 . . . . 0.0 111.152 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.29 -42.0 98.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.346 0.975 . . . . 0.0 113.485 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.99 -53.84 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.02 0.827 . . . . 0.0 110.612 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.81 -30.67 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.93 -30.78 70.54 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.795 1.664 . . . . 0.0 113.762 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.81 -56.92 6.18 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.172 0.986 . . . . 0.0 110.945 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 125.788 1.635 . . . . 0.0 113.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -55.67 -44.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.458 0.703 . . . . 0.0 111.651 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -44.43 97.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.346 0.659 . . . . 0.0 112.327 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.64 91.2 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.725 0.81 . . . . 0.0 112.496 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.43 -42.43 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.701 0.8 . . . . 0.0 111.406 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -58.22 -44.41 88.17 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.15 -0.969 . . . . 0.0 112.082 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -64.55 -51.51 62.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.733 0.813 . . . . 0.0 112.547 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.1 -30.34 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.2 -0.937 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -42.04 95.37 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.647 1.179 . . . . 0.0 112.203 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 125.703 1.601 . . . . 0.0 113.621 177.112 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -58.15 -38.45 76.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.122 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.31 -42.14 72.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.071 0.948 . . . . 0.0 111.365 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.89 -51.42 69.71 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.329 0.513 . . . . 0.0 111.365 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.0 mt -55.72 -43.11 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.98 1.312 . . . . 0.0 111.211 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -58.27 -46.57 85.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.777 0.831 . . . . 0.0 112.494 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.18 -53.82 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.0 0.92 . . . . 0.0 111.106 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.37 -24.14 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.3 -22.89 51.99 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.795 1.664 . . . . 0.0 113.514 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.96 -57.96 4.62 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.417 1.108 . . . . 0.0 110.37 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 125.642 1.577 . . . . 0.0 113.744 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.2 mt . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.67 -40.12 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.143 0.977 . . . . 0.0 111.893 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.59 -45.32 94.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.207 1.003 . . . . 0.0 112.031 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.65 93.43 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 0.0 111.997 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.0 -41.25 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.168 0.987 . . . . 0.0 111.669 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.98 -41.36 97.93 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.825 -1.172 . . . . 0.0 112.427 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 m -64.85 -51.51 61.65 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.67 0.788 . . . . 0.0 112.386 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -64.7 -32.42 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.108 0.867 . . . . 0.0 112.467 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.66 -32.47 63.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.067 1.347 . . . . 0.0 113.17 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -54.8 -45.98 74.42 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.538 1.135 . . . . 0.0 112.358 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.84 -42.92 84.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.13 1.372 . . . . 0.0 112.329 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -58.15 -53.01 63.15 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.451 0.569 . . . . 0.0 111.392 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -56.06 -40.84 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.806 1.642 . . . . 0.0 110.94 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.8 mmm -57.2 -47.83 80.29 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.09 0.956 . . . . 0.0 112.335 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.02 -53.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.811 0.844 . . . . 0.0 111.284 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.12 -30.42 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.49 -19.63 71.0 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.724 1.63 . . . . 0.0 113.675 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.71 -50.16 20.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.01 1.405 . . . . 0.0 110.559 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 126.024 1.73 . . . . 0.0 112.803 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -56.78 -40.81 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.371 1.468 . . . . 0.0 111.672 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.99 -43.8 98.34 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.984 0.914 . . . . 0.0 112.332 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.08 92.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.5 -40.37 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.003 0.921 . . . . 0.0 111.824 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.6 mt -62.91 -43.54 98.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.011 -1.056 . . . . 0.0 111.607 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -64.4 -49.06 73.05 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.568 0.747 . . . . 0.0 112.173 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.24 -34.21 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.8 0.727 . . . . 0.0 112.583 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.41 -31.45 65.85 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.305 1.442 . . . . 0.0 113.939 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 125.162 1.385 . . . . 0.0 113.655 176.228 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -55.31 -50.21 70.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.202 1.401 . . . . 0.0 112.792 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.63 -43.52 98.71 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 111.336 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -56.31 -47.73 78.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.714 0.688 . . . . 0.0 111.903 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.05 -40.25 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 111.312 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 mtp -64.67 -41.12 96.3 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.251 -0.906 . . . . 0.0 113.186 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -62.12 -53.66 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.247 1.019 . . . . 0.0 110.768 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.81 -29.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.82 93.48 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.683 1.135 . . . . 0.0 112.9 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.55 89.85 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.078 0.939 . . . . 0.0 112.149 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.315 1.446 . . . . 0.0 112.89 175.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -58.14 -42.11 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.801 0.84 . . . . 0.0 111.627 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -44.63 93.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.001 0.92 . . . . 0.0 112.28 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -36.62 80.57 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.862 0.865 . . . . 0.0 112.689 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.34 -40.02 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.115 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.31 -44.86 95.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.877 -1.139 . . . . 0.0 112.418 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -66.08 -47.6 73.71 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.771 0.714 . . . . 0.0 112.827 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.18 -33.07 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.356 0.98 . . . . 0.0 112.453 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -62.37 -39.01 91.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.004 0.922 . . . . 0.0 111.856 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 124.715 1.206 . . . . 0.0 113.157 177.618 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -55.22 -42.94 74.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.838 1.255 . . . . 0.0 112.997 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.61 -42.69 91.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 111.55 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -60.22 -49.15 78.75 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.678 0.791 . . . . 0.0 112.14 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -55.01 -45.0 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.265 1.426 . . . . 0.0 111.03 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.5 mmm -56.56 -42.93 79.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.194 0.998 . . . . 0.0 112.905 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.68 -53.8 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.05 0.94 . . . . 0.0 111.252 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.27 -26.98 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.82 -30.41 66.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.43 1.014 . . . . 0.0 113.471 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.81 -51.65 33.86 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.308 1.054 . . . . 0.0 111.737 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.884 1.673 . . . . 0.0 112.793 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -58.56 -41.46 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.748 0.819 . . . . 0.0 112.08 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.53 -42.43 96.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.73 1.212 . . . . 0.0 112.649 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.96 92.15 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.628 0.771 . . . . 0.0 111.875 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.33 -40.05 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.104 0.962 . . . . 0.0 111.716 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mt -60.85 -44.83 96.46 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.45 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 t -62.99 -51.58 66.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.915 0.886 . . . . 0.0 112.096 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -63.41 -33.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.319 -0.863 . . . . 0.0 112.518 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -61.98 -27.95 69.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.226 1.011 . . . . 0.0 113.036 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -50.73 -43.37 58.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.238 1.815 . . . . 0.0 112.469 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 31.6 mt -69.47 -42.51 74.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.16 1.384 . . . . 0.0 111.544 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -56.54 -47.64 79.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.299 0.64 . . . . 0.0 111.605 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.6 mt -54.45 -43.22 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.807 1.243 . . . . 0.0 111.339 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtm -60.84 -46.37 90.81 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.428 -0.795 . . . . 0.0 112.502 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.13 -53.68 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.308 1.043 . . . . 0.0 110.963 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 m -65.4 -29.8 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.74 87.38 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.869 1.224 . . . . 0.0 113.802 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.63 -46.5 93.6 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 118.323 1.061 . . . . 0.0 112.667 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.803 1.641 . . . . 0.0 112.722 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.7 -49.28 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.096 0.958 . . . . 0.0 111.52 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.55 -44.82 93.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.676 0.79 . . . . 0.0 112.813 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.13 83.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.455 0.702 . . . . 0.0 112.614 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.85 -41.89 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.265 1.026 . . . . 0.0 111.413 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.1 -43.2 95.72 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.874 -1.141 . . . . 0.0 112.275 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m -63.39 -51.41 65.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.476 0.711 . . . . 0.0 112.851 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.1 tt -64.72 -33.05 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.242 0.928 . . . . 0.0 112.859 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -61.07 -42.48 98.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 0.0 112.178 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 125.639 1.575 . . . . 0.0 114.828 176.254 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -57.2 -46.16 83.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.122 0.969 . . . . 0.0 112.907 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.15 -42.79 95.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.516 1.126 . . . . 0.0 112.113 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -58.31 -49.93 75.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.647 0.658 . . . . 0.0 111.647 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.38 -40.01 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.572 1.149 . . . . 0.0 111.527 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.5 mmt -59.33 -42.17 90.84 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.479 1.036 . . . . 0.0 112.843 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.29 -53.57 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.389 0.676 . . . . 0.0 111.013 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.21 -35.42 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.57 82.83 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.564 1.554 . . . . 0.0 112.616 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.28 58.22 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 125.926 1.691 . . . . 0.0 113.635 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.16 -41.97 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.892 1.277 . . . . 0.0 111.666 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -45.05 95.3 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.773 1.229 . . . . 0.0 112.344 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.05 -45.69 90.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.421 0.688 . . . . 0.0 112.055 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.75 -42.6 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.73 1.212 . . . . 0.0 111.393 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.3 -43.84 95.93 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.91 -1.119 . . . . 0.0 111.788 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.5 m -64.05 -50.77 67.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 112.681 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.73 -30.86 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.044 0.838 . . . . 0.0 112.614 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -61.14 -43.19 99.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.562 1.145 . . . . 0.0 111.636 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 0.0 113.924 177.729 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -56.5 -45.79 80.86 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.937 1.295 . . . . 0.0 112.241 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.81 -43.47 96.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.788 1.235 . . . . 0.0 111.569 175.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -57.42 -49.8 75.05 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.578 -0.701 . . . . 0.0 111.775 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mt -58.38 -39.12 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.894 1.278 . . . . 0.0 111.056 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmm -61.3 -43.59 98.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.663 0.785 . . . . 0.0 112.291 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.85 -53.58 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.794 0.838 . . . . 0.0 111.07 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.8 -38.21 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.979 0.511 . . . . 0.0 112.231 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.38 91.37 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.43 1.49 . . . . 0.0 112.915 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -47.87 84.98 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.179 0.99 . . . . 0.0 111.862 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 124.328 1.051 . . . . 0.0 113.093 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.65 -42.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.146 0.978 . . . . 0.0 111.848 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.37 -40.93 96.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.818 0.847 . . . . 0.0 112.296 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.37 97.43 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.802 -0.561 . . . . 0.0 111.221 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.71 -40.33 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.518 0.727 . . . . 0.0 112.16 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.45 -41.95 99.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.955 -1.091 . . . . 0.0 112.183 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t -67.1 -50.46 61.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 0.0 112.38 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.44 -33.32 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.099 -1.0 . . . . 0.0 112.54 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -58.34 -34.12 70.29 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.649 1.18 . . . . 0.0 113.729 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm . . . . . 0 N--CA 1.476 0.851 0 C-N-CA 125.271 1.428 . . . . 0.0 113.688 175.147 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -55.95 -45.56 78.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.86 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.93 -44.56 96.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.934 0.894 . . . . 0.0 111.931 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.26 -51.01 71.08 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.198 0.454 . . . . 0.0 111.611 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.86 -40.52 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.723 1.209 . . . . 0.0 111.116 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmt -60.8 -46.13 91.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.028 0.831 . . . . 0.0 112.519 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.16 -53.69 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.899 0.879 . . . . 0.0 111.155 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.17 -29.19 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.26 -31.85 78.59 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.482 1.515 . . . . 0.0 113.277 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.18 -43.41 80.49 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.408 1.104 . . . . 0.0 111.955 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.769 -0.085 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.16 -43.15 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.636 0.774 . . . . 0.0 111.558 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.94 -41.01 95.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.301 1.04 . . . . 0.0 111.956 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.66 79.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.447 0.699 . . . . 0.0 111.709 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.5 -41.35 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 111.613 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.09 -42.51 98.64 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.963 -1.086 . . . . 0.0 112.707 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 m -66.67 -51.42 56.26 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.579 0.752 . . . . 0.0 112.274 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.82 -33.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 119.48 1.036 . . . . 0.0 112.519 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -56.58 -34.03 66.76 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.115 0.966 . . . . 0.0 112.648 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -56.61 -47.16 80.23 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.337 1.055 . . . . 0.0 112.575 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.16 -42.35 94.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.573 1.149 . . . . 0.0 111.979 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.2 -48.77 77.96 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.472 0.578 . . . . 0.0 111.412 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.73 -38.99 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.075 1.35 . . . . 0.0 111.266 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.4 mtt -59.81 -41.54 91.48 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.389 0.995 . . . . 0.0 112.39 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.97 -53.78 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.13 0.972 . . . . 0.0 110.69 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.69 -26.22 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.0 -27.72 62.69 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.543 1.544 . . . . 0.0 113.97 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 -52.61 30.15 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 118.469 1.134 . . . . 0.0 111.187 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.399 1.479 . . . . 0.0 113.369 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.77 -41.94 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.36 1.064 . . . . 0.0 111.901 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -45.96 92.04 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.756 0.822 . . . . 0.0 112.356 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 -44.18 94.11 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.796 0.838 . . . . 0.0 112.274 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.72 -41.59 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.285 1.034 . . . . 0.0 111.486 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.64 -42.07 98.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.974 -1.079 . . . . 0.0 112.217 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.7 m -64.7 -49.29 71.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.778 0.831 . . . . 0.0 112.584 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.05 -30.79 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.219 0.918 . . . . 0.0 112.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -60.71 -28.04 68.35 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.388 1.075 . . . . 0.0 113.844 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt . . . . . 0 N--CA 1.478 0.945 0 C-N-CA 125.29 1.436 . . . . 0.0 113.639 175.038 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -56.78 -37.23 70.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.161 1.384 . . . . 0.0 112.906 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.62 -45.21 72.49 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.104 1.362 . . . . 0.0 111.448 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.38 -52.2 66.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.126 0.57 . . . . 0.0 111.889 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -39.85 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.282 1.433 . . . . 0.0 110.795 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 mmm -59.73 -51.39 69.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.915 . . . . 0.0 111.977 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.84 -51.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.595 0.758 . . . . 0.0 111.368 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 m -67.85 -37.55 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.157 0.583 . . . . 0.0 111.977 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.77 99.52 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.545 1.545 . . . . 0.0 112.811 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.17 -45.82 93.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 117.949 0.874 . . . . 0.0 111.913 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.903 1.281 . . . . 0.0 112.871 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.63 -44.91 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.963 0.905 . . . . 0.0 111.722 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.8 -37.82 85.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.983 0.913 . . . . 0.0 112.478 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.28 86.12 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.545 0.611 . . . . 0.0 111.471 174.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' HG22 ' A' ' 24' ' ' ILE . 43.3 t -66.38 -41.81 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.287 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.54 -42.28 96.22 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.891 -1.131 . . . . 0.0 112.544 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -66.87 -49.51 65.42 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.292 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.413 HG22 ' HA ' ' A' ' 21' ' ' VAL . 13.6 tt -63.32 -35.75 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.583 1.083 . . . . 0.0 112.454 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -35.74 69.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.554 1.141 . . . . 0.0 111.996 174.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.7 tttt . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 126.108 1.763 . . . . 0.0 114.253 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -53.01 -44.73 67.5 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.577 1.551 . . . . 0.0 111.718 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.96 -45.21 86.66 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.791 1.236 . . . . 0.0 111.432 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.11 -52.85 63.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 111.244 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.38 -42.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.977 1.311 . . . . 0.0 111.151 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -46.45 80.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.237 1.015 . . . . 0.0 112.475 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.05 -53.9 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.23 1.012 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.1 -27.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.93 -25.52 64.18 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.735 1.636 . . . . 0.0 113.819 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.02 -54.04 15.93 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.636 1.218 . . . . 0.0 110.589 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.636 1.574 . . . . 0.0 113.287 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.7 -40.01 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.758 -0.589 . . . . 0.0 112.023 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -42.24 92.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.264 1.026 . . . . 0.0 112.333 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.96 87.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.726 0.81 . . . . 0.0 111.854 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.7 -41.96 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 111.901 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.7 -40.59 95.58 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.017 -1.052 . . . . 0.0 112.385 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -66.62 -51.53 55.27 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.762 0.825 . . . . 0.0 112.101 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 tt -63.72 -32.43 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.391 -0.818 . . . . 0.0 112.61 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -56.97 -36.79 70.73 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.394 1.477 . . . . 0.0 113.372 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 C-N-CA 125.224 1.41 . . . . 0.0 113.556 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -54.31 -38.73 66.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.959 1.304 . . . . 0.0 113.676 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.17 -39.61 71.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.279 1.032 . . . . 0.0 111.951 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.18 -48.83 79.09 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.426 0.557 . . . . 0.0 111.463 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.5 mt -57.94 -39.71 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.004 1.321 . . . . 0.0 110.978 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.03 -38.3 88.18 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.27 -0.894 . . . . 0.0 113.395 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.9 mt -65.31 -53.86 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.009 0.924 . . . . 0.0 110.459 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.33 -22.07 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.56 -26.22 59.42 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.869 1.7 . . . . 0.0 114.402 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.9 8.66 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.673 1.236 . . . . 0.0 111.232 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 125.765 1.626 . . . . 0.0 113.381 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.32 -43.12 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.922 1.289 . . . . 0.0 111.752 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.32 -42.65 99.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.303 1.041 . . . . 0.0 112.353 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.1 97.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.525 -0.734 . . . . 0.0 111.715 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.07 -35.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.588 1.155 . . . . 0.0 111.716 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.0 -45.23 78.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.673 -1.267 . . . . 0.0 110.754 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 m -62.72 -47.43 83.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.386 1.074 . . . . 0.0 112.472 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 tt -66.82 -35.75 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 118.962 0.801 . . . . 0.0 112.571 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -59.87 -24.48 64.28 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.087 1.312 . . . . 0.0 113.461 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.99 175.374 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 pttm . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -59.04 -35.53 73.47 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 0.0 113.704 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -54.78 -46.32 74.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.698 1.599 . . . . 0.0 112.968 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.76 -45.12 91.24 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.932 0.893 . . . . 0.0 111.87 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.06 -50.08 74.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.385 0.539 . . . . 0.0 111.763 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -58.08 -37.32 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.213 1.405 . . . . 0.0 110.852 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.6 mtt -61.95 -44.32 97.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.83 1.196 . . . . 0.0 112.228 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.46 -53.71 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.025 0.93 . . . . 0.0 110.729 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.38 -27.98 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.23 -40.61 99.25 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.532 1.539 . . . . 0.0 112.989 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 -37.16 94.35 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 118.04 0.92 . . . . 0.0 112.256 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -57.28 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.552 1.541 . . . . 0.0 112.233 174.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.17 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.466 1.106 . . . . 0.0 111.492 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.66 27.57 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.647 1.594 . . . . 0.0 114.522 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -35.71 65.81 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.734 1.267 . . . . 0.0 111.686 175.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -58.17 -46.04 86.44 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.223 1.009 . . . . 0.0 112.008 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 62.1 mt -70.35 -48.67 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.234 1.414 . . . . 0.0 109.98 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.75 -44.58 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.055 0.942 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.5 -45.79 92.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.495 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.4 81.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.363 0.665 . . . . 0.0 112.104 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.18 -39.97 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.072 0.949 . . . . 0.0 111.692 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.24 -42.64 99.24 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.798 -1.189 . . . . 0.0 111.992 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -63.26 -51.53 65.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 112.193 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -64.41 -31.63 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.308 -0.87 . . . . 0.0 112.653 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -34.85 76.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.827 1.251 . . . . 0.0 112.561 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -26.66 62.23 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.259 1.024 . . . . 0.0 112.659 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.946 1.698 . . . . 0.0 113.477 179.054 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -60.91 -46.57 90.11 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 121.219 1.827 . . . . 0.0 113.826 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -52.66 -41.32 63.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.929 1.291 . . . . 0.0 113.003 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -68.83 -47.7 65.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.111 1.764 . . . . 0.0 111.651 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.79 -49.33 76.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.388 0.54 . . . . 0.0 111.96 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.37 -37.11 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 111.167 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -43.33 97.5 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.426 1.012 . . . . 0.0 112.801 175.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.85 -53.67 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.481 0.712 . . . . 0.0 110.846 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.99 -34.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.018 0.527 . . . . 0.0 112.4 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.53 77.48 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.426 1.489 . . . . 0.0 113.838 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.85 -56.59 12.16 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.058 0.929 . . . . 0.0 111.6 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -51.63 69.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.397 1.479 . . . . 0.0 113.629 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.68 -38.65 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.123 1.369 . . . . 0.0 111.326 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.41 92.9 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.078 0.847 . . . . 0.0 113.029 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -37.51 68.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.538 1.135 . . . . 0.0 113.084 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -58.61 -41.52 86.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.255 1.022 . . . . 0.0 112.372 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.68 -48.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.52 1.128 . . . . 0.0 109.952 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -57.44 -40.35 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.858 0.863 . . . . 0.0 111.954 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -43.24 91.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.137 0.975 . . . . 0.0 112.277 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.56 84.86 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.794 0.838 . . . . 0.0 111.591 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.97 -41.16 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.83 -43.43 94.58 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.905 -1.122 . . . . 0.0 112.007 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 t -67.32 -48.14 68.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.589 0.756 . . . . 0.0 112.394 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.9 tt -64.15 -31.86 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.372 -0.83 . . . . 0.0 112.453 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -61.49 -40.51 94.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.27 0.941 . . . . 0.0 112.531 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -68.43 -22.28 64.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.452 1.101 . . . . 0.0 112.541 179.582 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.629 0.252 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -64.57 -37.96 89.36 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.966 0.906 . . . . 0.0 112.861 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -53.98 -42.95 69.55 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.572 1.549 . . . . 0.0 113.056 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.58 -47.93 83.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.287 1.035 . . . . 0.0 112.156 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.09 -51.75 68.7 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.915 -0.491 . . . . 0.0 111.65 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -54.86 -39.51 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.547 1.539 . . . . 0.0 111.276 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -48.84 80.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.186 0.995 . . . . 0.0 111.989 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.3 mt -65.13 -53.82 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 110.977 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -69.28 -34.04 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.62 90.42 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.701 1.619 . . . . 0.0 112.897 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -49.32 59.82 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.273 1.037 . . . . 0.0 111.049 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -58.05 9.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.062 1.745 . . . . 0.0 113.371 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.61 -41.9 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.554 1.142 . . . . 0.0 111.228 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.94 -31.22 71.65 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.218 0.913 . . . . 0.0 113.569 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -37.58 61.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.663 1.232 . . . . 0.0 112.097 175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.3 mmm-85 -59.43 -41.16 88.94 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.061 1.344 . . . . 0.0 111.88 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.68 -50.13 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.994 1.718 . . . . 0.0 110.095 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.8 -40.58 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.738 . . . . 0.0 111.701 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -61.58 -38.32 87.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.358 1.063 . . . . 0.0 112.468 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.55 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.425 0.69 . . . . 0.0 111.349 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.1 -42.3 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.607 1.163 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.84 -39.88 95.72 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.747 -1.221 . . . . 0.0 112.302 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.27 -51.44 60.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.268 1.027 . . . . 0.0 112.136 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.8 -34.4 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.289 -0.882 . . . . 0.0 112.546 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -56.33 -31.76 64.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.978 1.311 . . . . 0.0 113.585 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -76.1 -13.64 60.2 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.807 1.243 . . . . 0.0 113.779 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 pttt . . . . . 0 C--O 1.253 1.271 0 C-N-CA 125.539 1.536 . . . . 0.0 112.964 177.484 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -51.44 -37.3 47.97 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 120.305 1.411 . . . . 0.0 114.155 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -52.69 -43.46 65.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.497 1.519 . . . . 0.0 113.032 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -64.6 -46.52 82.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 111.509 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -56.59 -50.75 71.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.999 0.519 . . . . 0.0 111.472 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.21 -42.82 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.443 1.097 . . . . 0.0 111.07 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.84 -44.81 93.88 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.41 1.005 . . . . 0.0 112.815 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.96 -53.78 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.857 0.863 . . . . 0.0 111.159 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.0 m -69.39 -24.78 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.64 -31.18 66.75 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.39 1.472 . . . . 0.0 113.54 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.25 75.79 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.391 1.095 . . . . 0.0 111.734 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -54.28 48.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.421 1.488 . . . . 0.0 112.992 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -64.88 -40.17 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 111.476 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.15 -31.79 56.51 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.836 1.207 . . . . 0.0 113.918 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.11 -40.34 70.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.511 1.156 . . . . 0.0 112.502 177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -61.01 -38.69 86.98 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.94 0.791 . . . . 0.0 112.55 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.0 mt -68.4 -51.52 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.92 1.288 . . . . 0.0 109.866 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.93 -41.56 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.829 0.852 . . . . 0.0 111.78 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.89 -40.61 96.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.851 0.86 . . . . 0.0 112.685 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.83 91.75 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.734 -0.604 . . . . 0.0 111.673 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.73 -42.38 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.792 0.837 . . . . 0.0 111.962 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.01 -33.97 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.527 -1.358 . . . . 0.0 113.371 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -72.34 -50.94 23.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.095 0.958 . . . . 0.0 111.782 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.62 -31.69 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.244 -0.91 . . . . 0.0 112.951 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -58.52 -30.89 67.41 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.921 -1.112 . . . . 0.0 113.721 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -71.5 -21.43 61.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.254 1.331 0 CA-C-O 117.251 -1.357 . . . . 0.0 113.571 -178.477 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.1 mptt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 119.69 -0.195 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -55.6 -51.16 68.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.566 1.546 . . . . 0.0 112.717 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -52.33 -53.79 39.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.268 1.427 . . . . 0.0 111.862 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.96 -45.99 89.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.45 1.5 . . . . 0.0 112.032 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -55.25 -50.09 70.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.376 0.671 . . . . 0.0 111.504 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mt -58.16 -38.15 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.678 1.191 . . . . 0.0 111.315 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.9 mtp -64.98 -43.5 92.4 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.476 1.035 . . . . 0.0 112.643 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.26 -53.71 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.971 0.908 . . . . 0.0 110.723 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.03 -26.84 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.4 -37.0 79.45 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.567 1.556 . . . . 0.0 113.022 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.97 -51.87 55.87 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.671 0.736 . . . . 0.0 111.404 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.85 -53.45 52.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.177 1.791 . . . . 0.0 113.348 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.8 -45.01 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.78 -39.68 91.76 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.23 0.919 . . . . 0.0 112.75 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -35.96 73.09 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.542 1.137 . . . . 0.0 113.145 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -57.87 -42.95 85.61 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 112.285 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mt -67.59 -50.81 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.461 1.505 . . . . 0.0 109.446 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.2 -45.23 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.303 1.041 . . . . 0.0 112.04 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.09 -42.97 91.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 112.482 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.53 79.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.171 0.589 . . . . 0.0 111.493 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.94 -41.89 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.154 0.582 . . . . 0.0 112.112 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.32 -44.21 95.66 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.037 -1.039 . . . . 0.0 112.327 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 t -63.88 -51.5 64.26 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.755 0.822 . . . . 0.0 111.791 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.8 tt -63.45 -30.85 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.292 -0.88 . . . . 0.0 112.643 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -40.86 97.89 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.411 1.084 . . . . 0.0 112.036 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -71.02 -22.87 62.1 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.066 1.346 . . . . 0.0 113.723 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 pttt . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.152 -178.233 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.9 tttt . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -46.36 -37.35 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.247 2.219 . . . . 0.0 114.675 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -51.54 -39.77 58.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.205 1.802 . . . . 0.0 113.742 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.04 -31.53 71.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.414 1.086 . . . . 0.0 112.474 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -66.01 -50.77 63.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.497 0.665 . . . . 0.0 110.486 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.7 mt -62.07 -35.86 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.578 1.551 . . . . 0.0 110.851 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -56.35 -39.47 72.9 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.711 1.204 . . . . 0.0 112.516 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.9 mt -68.92 -53.85 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.377 1.071 . . . . 0.0 110.597 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.96 -29.6 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.392 0.677 . . . . 0.0 112.727 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.09 67.6 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.849 1.214 . . . . 0.0 114.284 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.54 -52.06 37.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.708 1.254 . . . . 0.0 111.849 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -52.69 64.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.498 1.519 . . . . 0.0 112.9 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.45 -41.54 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.697 1.199 . . . . 0.0 111.609 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.46 -44.21 95.46 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.366 0.984 . . . . 0.0 112.643 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -45.72 74.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.196 0.998 . . . . 0.0 112.089 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -56.56 -45.57 81.21 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.579 1.152 . . . . 0.0 112.984 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -64.44 -51.14 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.553 1.141 . . . . 0.0 109.63 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.49 -42.2 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.527 1.131 . . . . 0.0 111.869 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.52 -44.14 97.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.716 1.606 . . . . 0.0 112.692 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -45.58 88.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.131 0.573 . . . . 0.0 111.612 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.47 -40.48 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.373 1.069 . . . . 0.0 111.8 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.34 -43.45 98.79 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.668 -1.27 . . . . 0.0 112.481 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.5 m -63.94 -51.16 65.72 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.188 0.995 . . . . 0.0 112.16 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.48 -31.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.845 0.748 . . . . 0.0 112.43 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.26 -40.43 95.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.438 1.017 . . . . 0.0 112.505 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.78 -14.71 60.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.485 1.293 0 C-N-CA 126.522 1.929 . . . . 0.0 113.221 -179.418 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.018 -0.039 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -60.42 -37.64 81.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.213 1.005 . . . . 0.0 113.215 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -57.13 -44.79 83.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.308 1.043 . . . . 0.0 112.112 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -44.77 95.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.683 1.193 . . . . 0.0 111.696 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.57 -51.53 69.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.271 0.487 . . . . 0.0 111.761 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.93 -39.82 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.875 1.27 . . . . 0.0 111.157 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.81 -47.55 85.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.238 0.926 . . . . 0.0 112.609 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.61 -53.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.0 0.92 . . . . 0.0 110.783 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.8 m -66.36 -38.68 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.144 0.578 . . . . 0.0 112.255 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.83 -32.59 84.69 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.336 1.446 . . . . 0.0 113.38 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.21 -53.27 41.02 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.374 1.087 . . . . 0.0 112.078 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.45 46.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.983 1.313 . . . . 0.0 113.159 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.6 -32.96 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.11 0.964 . . . . 0.0 111.677 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.38 -40.74 23.51 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.935 1.731 . . . . 0.0 113.537 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -39.5 79.38 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.133 0.973 . . . . 0.0 112.483 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -62.94 -40.31 97.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.279 1.032 . . . . 0.0 112.21 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.85 -45.31 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.921 1.288 . . . . 0.0 110.228 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -56.19 -40.5 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.017 0.927 . . . . 0.0 111.551 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -43.96 98.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.749 0.819 . . . . 0.0 112.613 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.76 90.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.729 0.811 . . . . 0.0 111.925 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.8 -40.64 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.966 0.906 . . . . 0.0 111.825 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.95 -42.86 99.59 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.872 -1.142 . . . . 0.0 112.041 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.0 t -63.16 -51.48 66.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.404 0.682 . . . . 0.0 112.066 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tt -66.22 -26.45 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.359 -0.838 . . . . 0.0 112.687 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -66.05 -39.58 90.23 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.92 -1.112 . . . . 0.0 112.763 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.88 -28.46 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.122 0.969 . . . . 0.0 112.362 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 pttt . . . . . 0 C--O 1.253 1.279 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.178 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.6 mttp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.675 -0.203 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -59.71 -33.66 71.9 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -54.72 -44.04 73.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.465 1.106 . . . . 0.0 112.97 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.62 -45.27 91.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.483 1.113 . . . . 0.0 111.816 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.92 -50.95 71.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.031 0.532 . . . . 0.0 111.784 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.86 -40.29 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.654 1.582 . . . . 0.0 111.152 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.29 -42.0 98.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.346 0.975 . . . . 0.0 113.485 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.99 -53.84 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.02 0.827 . . . . 0.0 110.612 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.81 -30.67 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.93 -30.78 70.54 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.795 1.664 . . . . 0.0 113.762 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.81 -56.92 6.18 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.172 0.986 . . . . 0.0 110.945 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -56.33 23.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.788 1.635 . . . . 0.0 113.478 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.1 -41.94 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.105 1.362 . . . . 0.0 110.776 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.09 62.74 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.4 1.0 . . . . 0.0 112.727 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -42.81 68.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.56 1.144 . . . . 0.0 112.998 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -40.52 97.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.148 0.979 . . . . 0.0 112.131 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.15 -48.01 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.198 0.999 . . . . 0.0 109.838 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -55.67 -44.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.458 0.703 . . . . 0.0 111.651 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -44.43 97.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.346 0.659 . . . . 0.0 112.327 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.64 91.2 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.725 0.81 . . . . 0.0 112.496 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.43 -42.43 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.701 0.8 . . . . 0.0 111.406 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -58.22 -44.41 88.17 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.15 -0.969 . . . . 0.0 112.082 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -64.55 -51.51 62.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.733 0.813 . . . . 0.0 112.547 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.1 -30.34 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.2 -0.937 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -42.04 95.37 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.647 1.179 . . . . 0.0 112.203 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -72.05 -21.36 61.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.703 1.601 . . . . 0.0 113.621 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.574 1.95 . . . . 0.0 113.434 -169.354 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.9 mttt . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -40.73 11.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.583 1.953 . . . . 0.0 115.111 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -58.15 -38.45 76.62 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.05 1.34 . . . . 0.0 113.122 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.31 -42.14 72.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.071 0.948 . . . . 0.0 111.365 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.89 -51.42 69.71 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.329 0.513 . . . . 0.0 111.365 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.0 mt -55.72 -43.11 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.98 1.312 . . . . 0.0 111.211 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -58.27 -46.57 85.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.777 0.831 . . . . 0.0 112.494 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.18 -53.82 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.0 0.92 . . . . 0.0 111.106 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.37 -24.14 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.3 -22.89 51.99 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.795 1.664 . . . . 0.0 113.514 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.96 -57.96 4.62 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.417 1.108 . . . . 0.0 110.37 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -54.0 34.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.642 1.577 . . . . 0.0 113.744 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.35 -49.7 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.091 1.356 . . . . 0.0 110.836 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.79 -24.39 53.44 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.8 0.714 . . . . 0.0 113.989 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -31.86 62.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.43 1.092 . . . . 0.0 111.638 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -57.51 -35.9 70.86 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.4 1.0 . . . . 0.0 113.355 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.21 -49.22 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.699 1.6 . . . . 0.0 109.383 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.67 -40.12 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.143 0.977 . . . . 0.0 111.893 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.59 -45.32 94.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.207 1.003 . . . . 0.0 112.031 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.65 93.43 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 0.0 111.997 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.0 -41.25 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.168 0.987 . . . . 0.0 111.669 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.98 -41.36 97.93 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.825 -1.172 . . . . 0.0 112.427 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 m -64.85 -51.51 61.65 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.67 0.788 . . . . 0.0 112.386 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -64.7 -32.42 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.108 0.867 . . . . 0.0 112.467 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.66 -32.47 63.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.067 1.347 . . . . 0.0 113.17 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -13.72 60.41 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.028 1.731 . . . . 0.0 112.1 -177.662 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.159 0.028 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -60.59 -43.0 97.87 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 0.0 112.747 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -54.8 -45.98 74.42 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.538 1.135 . . . . 0.0 112.358 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.84 -42.92 84.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.13 1.372 . . . . 0.0 112.329 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -58.15 -53.01 63.15 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.451 0.569 . . . . 0.0 111.392 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.9 mt -56.06 -40.84 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.806 1.642 . . . . 0.0 110.94 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.8 mmm -57.2 -47.83 80.29 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.09 0.956 . . . . 0.0 112.335 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.02 -53.56 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.811 0.844 . . . . 0.0 111.284 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.12 -30.42 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.49 -19.63 71.0 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.724 1.63 . . . . 0.0 113.675 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.71 -50.16 20.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.01 1.405 . . . . 0.0 110.559 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -57.79 11.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.024 1.73 . . . . 0.0 112.803 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.23 -32.99 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.64 0.776 . . . . 0.0 111.438 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.24 -34.16 53.2 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.44 1.495 . . . . 0.0 113.949 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -42.1 70.96 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.064 1.432 . . . . 0.0 111.946 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -62.02 -39.13 91.24 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.739 1.216 . . . . 0.0 112.049 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.39 -51.95 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.444 1.497 . . . . 0.0 110.34 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -56.78 -40.81 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.371 1.468 . . . . 0.0 111.672 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.99 -43.8 98.34 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.984 0.914 . . . . 0.0 112.332 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.08 92.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.5 -40.37 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.003 0.921 . . . . 0.0 111.824 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.6 mt -62.91 -43.54 98.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.011 -1.056 . . . . 0.0 111.607 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -64.4 -49.06 73.05 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.568 0.747 . . . . 0.0 112.173 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.24 -34.21 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.8 0.727 . . . . 0.0 112.583 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.41 -31.45 65.85 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.305 1.442 . . . . 0.0 113.939 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -77.03 -10.8 59.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.162 1.385 . . . . 0.0 113.655 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.565 1.546 . . . . 0.0 113.07 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -47.32 -48.77 25.1 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.083 1.753 . . . . 0.0 113.377 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -55.31 -50.21 70.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.202 1.401 . . . . 0.0 112.792 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.63 -43.52 98.71 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 111.336 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -56.31 -47.73 78.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.714 0.688 . . . . 0.0 111.903 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.05 -40.25 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 111.312 175.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 mtp -64.67 -41.12 96.3 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.251 -0.906 . . . . 0.0 113.186 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -62.12 -53.66 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.247 1.019 . . . . 0.0 110.768 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.81 -29.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.82 93.48 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.683 1.135 . . . . 0.0 112.9 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.55 89.85 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.078 0.939 . . . . 0.0 112.149 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -55.61 32.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.315 1.446 . . . . 0.0 112.89 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.3 -38.25 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.672 0.789 . . . . 0.0 111.576 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.15 -23.47 12.34 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.585 1.564 . . . . 0.0 115.052 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -35.17 64.25 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.639 1.22 . . . . 0.0 111.713 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -36.55 74.57 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.562 1.073 . . . . 0.0 113.252 175.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.29 -50.2 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.282 1.433 . . . . 0.0 109.188 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -58.14 -42.11 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.801 0.84 . . . . 0.0 111.627 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -44.63 93.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.001 0.92 . . . . 0.0 112.28 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -36.62 80.57 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.862 0.865 . . . . 0.0 112.689 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.34 -40.02 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.115 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.31 -44.86 95.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.877 -1.139 . . . . 0.0 112.418 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -66.08 -47.6 73.71 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.771 0.714 . . . . 0.0 112.827 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.18 -33.07 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.356 0.98 . . . . 0.0 112.453 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -62.37 -39.01 91.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.004 0.922 . . . . 0.0 111.856 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -74.71 -19.64 60.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.715 1.206 . . . . 0.0 113.157 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.251 1.42 . . . . 0.0 112.077 172.592 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -60.51 -37.14 80.18 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 119.683 -1.886 . . . . 0.0 113.506 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -55.22 -42.94 74.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.838 1.255 . . . . 0.0 112.997 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.61 -42.69 91.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 111.55 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -60.22 -49.15 78.75 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.678 0.791 . . . . 0.0 112.14 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -55.01 -45.0 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.265 1.426 . . . . 0.0 111.03 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.5 mmm -56.56 -42.93 79.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.194 0.998 . . . . 0.0 112.905 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.68 -53.8 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.05 0.94 . . . . 0.0 111.252 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.27 -26.98 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.82 -30.41 66.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.43 1.014 . . . . 0.0 113.471 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.81 -51.65 33.86 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.308 1.054 . . . . 0.0 111.737 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.48 -55.28 30.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.884 1.673 . . . . 0.0 112.793 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.08 -38.66 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.238 1.015 . . . . 0.0 111.578 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.94 -44.53 96.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.156 0.884 . . . . 0.0 112.971 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -37.02 71.38 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.13 0.972 . . . . 0.0 112.272 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -57.23 -40.95 78.6 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.436 1.095 . . . . 0.0 112.476 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.54 -51.95 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.234 1.414 . . . . 0.0 109.809 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -58.56 -41.46 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.748 0.819 . . . . 0.0 112.08 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.53 -42.43 96.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.73 1.212 . . . . 0.0 112.649 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.96 92.15 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.628 0.771 . . . . 0.0 111.875 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.33 -40.05 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.104 0.962 . . . . 0.0 111.716 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mt -60.85 -44.83 96.46 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.066 -1.021 . . . . 0.0 111.45 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 t -62.99 -51.58 66.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.915 0.886 . . . . 0.0 112.096 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 tt -63.41 -33.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.319 -0.863 . . . . 0.0 112.518 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -61.98 -27.95 69.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.226 1.011 . . . . 0.0 113.036 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -14.36 50.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.576 1.55 . . . . 0.0 112.129 -177.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.336 -0.84 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -50.33 -33.41 20.16 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.435 1.471 . . . . 0.0 114.268 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -50.73 -43.37 58.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.238 1.815 . . . . 0.0 112.469 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 31.6 mt -69.47 -42.51 74.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.16 1.384 . . . . 0.0 111.544 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -56.54 -47.64 79.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.299 0.64 . . . . 0.0 111.605 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.6 mt -54.45 -43.22 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.807 1.243 . . . . 0.0 111.339 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtm -60.84 -46.37 90.81 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.428 -0.795 . . . . 0.0 112.502 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.13 -53.68 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.308 1.043 . . . . 0.0 110.963 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 m -65.4 -29.8 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.74 87.38 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.869 1.224 . . . . 0.0 113.802 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.63 -46.5 93.6 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 118.323 1.061 . . . . 0.0 112.667 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -54.64 41.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.803 1.641 . . . . 0.0 112.722 175.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.81 -36.74 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 111.421 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.14 52.59 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 112.905 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -40.51 82.92 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.888 0.844 . . . . 0.0 111.864 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -46.41 76.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.221 1.409 . . . . 0.0 112.025 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -66.68 -49.57 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.991 1.317 . . . . 0.0 109.887 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.7 -49.28 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.096 0.958 . . . . 0.0 111.52 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.55 -44.82 93.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.676 0.79 . . . . 0.0 112.813 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.13 83.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.455 0.702 . . . . 0.0 112.614 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.85 -41.89 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.265 1.026 . . . . 0.0 111.413 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.1 -43.2 95.72 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.874 -1.141 . . . . 0.0 112.275 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m -63.39 -51.41 65.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.476 0.711 . . . . 0.0 112.851 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.1 tt -64.72 -33.05 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.242 0.928 . . . . 0.0 112.859 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -61.07 -42.48 98.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 0.0 112.178 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -74.35 -15.22 60.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.639 1.575 . . . . 0.0 114.828 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 126.679 1.992 . . . . 0.0 113.181 -173.546 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -55.44 -49.12 73.27 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.224 1.81 . . . . 0.0 113.2 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -57.2 -46.16 83.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.122 0.969 . . . . 0.0 112.907 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.15 -42.79 95.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.516 1.126 . . . . 0.0 112.113 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -58.31 -49.93 75.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.647 0.658 . . . . 0.0 111.647 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.38 -40.01 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.572 1.149 . . . . 0.0 111.527 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.5 mmt -59.33 -42.17 90.84 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.479 1.036 . . . . 0.0 112.843 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.29 -53.57 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.389 0.676 . . . . 0.0 111.013 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.21 -35.42 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.57 82.83 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.564 1.554 . . . . 0.0 112.616 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.28 58.22 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.84 -54.19 47.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.926 1.691 . . . . 0.0 113.635 176.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.12 -44.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.436 0.694 . . . . 0.0 111.245 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.45 -35.46 85.38 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.604 1.097 . . . . 0.0 113.491 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -41.01 68.54 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.973 1.309 . . . . 0.0 112.22 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.56 1.144 . . . . 0.0 111.904 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.48 -51.59 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.92 1.688 . . . . 0.0 110.122 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.16 -41.97 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.892 1.277 . . . . 0.0 111.666 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -45.05 95.3 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.773 1.229 . . . . 0.0 112.344 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.05 -45.69 90.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.421 0.688 . . . . 0.0 112.055 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.75 -42.6 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.73 1.212 . . . . 0.0 111.393 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.3 -43.84 95.93 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.91 -1.119 . . . . 0.0 111.788 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.5 m -64.05 -50.77 67.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 112.681 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.73 -30.86 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.044 0.838 . . . . 0.0 112.614 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -61.14 -43.19 99.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.562 1.145 . . . . 0.0 111.636 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -73.8 -17.61 61.06 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 0.0 113.924 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.795 2.038 . . . . 0.0 112.885 -177.308 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.266 0.079 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.75 -47.46 84.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.945 1.298 . . . . 0.0 112.794 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -56.5 -45.79 80.86 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.937 1.295 . . . . 0.0 112.241 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.81 -43.47 96.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.788 1.235 . . . . 0.0 111.569 175.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -57.42 -49.8 75.05 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.578 -0.701 . . . . 0.0 111.775 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mt -58.38 -39.12 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.894 1.278 . . . . 0.0 111.056 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmm -61.3 -43.59 98.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.663 0.785 . . . . 0.0 112.291 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.85 -53.58 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.794 0.838 . . . . 0.0 111.07 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.8 -38.21 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.979 0.511 . . . . 0.0 112.231 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.38 91.37 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.43 1.49 . . . . 0.0 112.915 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -47.87 84.98 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.179 0.99 . . . . 0.0 111.862 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -56.81 17.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.328 1.051 . . . . 0.0 113.093 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.25 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.855 0.862 . . . . 0.0 111.674 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.41 -26.91 57.49 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.221 1.391 . . . . 0.0 114.121 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -40.06 72.65 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.62 1.21 . . . . 0.0 111.47 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -60.0 -38.54 82.95 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.404 -0.81 . . . . 0.0 112.532 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm -68.28 -50.32 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.729 1.211 . . . . 0.0 110.133 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.65 -42.93 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.146 0.978 . . . . 0.0 111.848 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.37 -40.93 96.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.818 0.847 . . . . 0.0 112.296 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.37 97.43 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.802 -0.561 . . . . 0.0 111.221 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.71 -40.33 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.518 0.727 . . . . 0.0 112.16 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.45 -41.95 99.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.955 -1.091 . . . . 0.0 112.183 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t -67.1 -50.46 61.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 0.0 112.38 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.44 -33.32 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.099 -1.0 . . . . 0.0 112.54 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -58.34 -34.12 70.29 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.649 1.18 . . . . 0.0 113.729 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -74.02 -15.39 61.09 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.271 1.428 . . . . 0.0 113.688 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.33 1.852 . . . . 0.0 111.371 -173.816 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.668 0.747 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -69.42 -36.94 77.19 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 120.809 -1.182 . . . . 0.0 112.479 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -55.95 -45.56 78.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.86 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.93 -44.56 96.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.934 0.894 . . . . 0.0 111.931 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -57.26 -51.01 71.08 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.198 0.454 . . . . 0.0 111.611 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.86 -40.52 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.723 1.209 . . . . 0.0 111.116 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmt -60.8 -46.13 91.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.028 0.831 . . . . 0.0 112.519 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -67.16 -53.69 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.899 0.879 . . . . 0.0 111.155 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.17 -29.19 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.26 -31.85 78.59 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.482 1.515 . . . . 0.0 113.277 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.18 -43.41 80.49 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.408 1.104 . . . . 0.0 111.955 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -55.99 26.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.0 -37.66 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.581 0.752 . . . . 0.0 111.281 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.9 -34.73 38.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.91 1.719 . . . . 0.0 114.142 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.16 -33.86 63.31 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.255 1.022 . . . . 0.0 112.529 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -58.94 -43.33 91.21 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.431 1.014 . . . . 0.0 112.275 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.78 -49.68 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.312 1.045 . . . . 0.0 110.769 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.16 -43.15 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.636 0.774 . . . . 0.0 111.558 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.94 -41.01 95.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.301 1.04 . . . . 0.0 111.956 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.66 79.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.447 0.699 . . . . 0.0 111.709 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.5 -41.35 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 111.613 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.09 -42.51 98.64 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.963 -1.086 . . . . 0.0 112.707 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 m -66.67 -51.42 56.26 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.579 0.752 . . . . 0.0 112.274 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.82 -33.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 119.48 1.036 . . . . 0.0 112.519 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -56.58 -34.03 66.76 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.115 0.966 . . . . 0.0 112.648 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.0 -15.23 58.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.7 pttt . . . . . 0 C--O 1.254 1.297 0 CA-C-O 117.069 -1.443 . . . . 0.0 113.749 -176.056 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -60.75 -34.83 75.02 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.107 1.321 . . . . 0.0 114.345 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -56.61 -47.16 80.23 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.337 1.055 . . . . 0.0 112.575 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.16 -42.35 94.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.573 1.149 . . . . 0.0 111.979 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.2 -48.77 77.96 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.472 0.578 . . . . 0.0 111.412 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.73 -38.99 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.075 1.35 . . . . 0.0 111.266 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 31.4 mtt -59.81 -41.54 91.48 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.389 0.995 . . . . 0.0 112.39 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.97 -53.78 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.13 0.972 . . . . 0.0 110.69 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.69 -26.22 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.0 -27.72 62.69 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.543 1.544 . . . . 0.0 113.97 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 -52.61 30.15 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 118.469 1.134 . . . . 0.0 111.187 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -55.0 39.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.399 1.479 . . . . 0.0 113.369 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.06 -31.14 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.839 0.856 . . . . 0.0 111.531 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.12 -36.13 27.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.652 1.596 . . . . 0.0 113.911 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -37.98 76.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.423 1.111 . . . . 0.0 113.023 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -62.44 -45.4 93.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.345 1.058 . . . . 0.0 111.86 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 mt -64.07 -47.23 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.23 1.412 . . . . 0.0 109.564 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.77 -41.94 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.36 1.064 . . . . 0.0 111.901 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -45.96 92.04 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.756 0.822 . . . . 0.0 112.356 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 -44.18 94.11 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.796 0.838 . . . . 0.0 112.274 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.72 -41.59 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.285 1.034 . . . . 0.0 111.486 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.64 -42.07 98.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.974 -1.079 . . . . 0.0 112.217 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.7 m -64.7 -49.29 71.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.778 0.831 . . . . 0.0 112.584 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tt -66.05 -30.79 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.219 0.918 . . . . 0.0 112.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -60.71 -28.04 68.35 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.388 1.075 . . . . 0.0 113.844 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -78.07 -15.12 59.18 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.29 1.436 . . . . 0.0 113.639 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.585 1.554 . . . . 0.0 112.428 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -51.34 -32.37 25.23 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.998 1.719 . . . . 0.0 115.617 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -56.78 -37.23 70.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.161 1.384 . . . . 0.0 112.906 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.62 -45.21 72.49 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.104 1.362 . . . . 0.0 111.448 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.38 -52.2 66.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.126 0.57 . . . . 0.0 111.889 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -39.85 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.282 1.433 . . . . 0.0 110.795 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.6 mmm -59.73 -51.39 69.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.986 0.915 . . . . 0.0 111.977 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.84 -51.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.595 0.758 . . . . 0.0 111.368 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 m -67.85 -37.55 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.157 0.583 . . . . 0.0 111.977 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.77 99.52 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.545 1.545 . . . . 0.0 112.811 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.17 -45.82 93.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 117.949 0.874 . . . . 0.0 111.913 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -51.71 67.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.903 1.281 . . . . 0.0 112.871 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.47 -44.47 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.066 0.546 . . . . 0.0 111.777 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.77 64.83 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.296 0.951 . . . . 0.0 114.162 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -40.18 67.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.672 1.236 . . . . 0.0 111.886 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -58.88 -36.95 75.49 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.787 1.235 . . . . 0.0 111.875 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.85 -50.03 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.551 1.541 . . . . 0.0 110.692 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.63 -44.91 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.963 0.905 . . . . 0.0 111.722 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.8 -37.82 85.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.983 0.913 . . . . 0.0 112.478 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.28 86.12 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.545 0.611 . . . . 0.0 111.471 174.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' HG22 ' A' ' 24' ' ' ILE . 43.3 t -66.38 -41.81 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.287 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.54 -42.28 96.22 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.891 -1.131 . . . . 0.0 112.544 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -66.87 -49.51 65.42 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.292 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.413 HG22 ' HA ' ' A' ' 21' ' ' VAL . 13.6 tt -63.32 -35.75 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.583 1.083 . . . . 0.0 112.454 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -35.74 69.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.554 1.141 . . . . 0.0 111.996 174.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.53 -11.52 59.15 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.108 1.763 . . . . 0.0 114.253 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 116.992 -1.48 . . . . 0.0 113.243 -178.49 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.9 pttp . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -54.93 -30.56 58.89 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 121.152 1.796 . . . . 0.0 115.468 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -53.01 -44.73 67.5 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.577 1.551 . . . . 0.0 111.718 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.96 -45.21 86.66 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.791 1.236 . . . . 0.0 111.432 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.11 -52.85 63.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.434 0.694 . . . . 0.0 111.244 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.38 -42.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.977 1.311 . . . . 0.0 111.151 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -46.45 80.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.237 1.015 . . . . 0.0 112.475 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.05 -53.9 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.23 1.012 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.1 -27.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.93 -25.52 64.18 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.735 1.636 . . . . 0.0 113.819 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.02 -54.04 15.93 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 118.636 1.218 . . . . 0.0 110.589 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -54.67 43.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.636 1.574 . . . . 0.0 113.287 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.47 -35.47 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.38 1.072 . . . . 0.0 111.475 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.94 96.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.041 0.829 . . . . 0.0 112.252 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -44.36 66.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.899 1.279 . . . . 0.0 112.106 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -43.57 76.33 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.949 1.3 . . . . 0.0 112.55 175.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.82 -47.69 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.847 1.259 . . . . 0.0 109.903 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.7 -40.01 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.758 -0.589 . . . . 0.0 112.023 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -42.24 92.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.264 1.026 . . . . 0.0 112.333 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.96 87.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.726 0.81 . . . . 0.0 111.854 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.7 -41.96 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 111.901 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.7 -40.59 95.58 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.017 -1.052 . . . . 0.0 112.385 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -66.62 -51.53 55.27 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.762 0.825 . . . . 0.0 112.101 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 tt -63.72 -32.43 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.391 -0.818 . . . . 0.0 112.61 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -56.97 -36.79 70.73 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.394 1.477 . . . . 0.0 113.372 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -11.85 58.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.224 1.41 . . . . 0.0 113.556 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.275 0 C-N-CA 127.364 2.266 . . . . 0.0 112.866 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -49.93 -36.53 28.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 125.843 1.657 . . . . 0.0 114.702 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -54.31 -38.73 66.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.959 1.304 . . . . 0.0 113.676 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.17 -39.61 71.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.279 1.032 . . . . 0.0 111.951 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.18 -48.83 79.09 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.426 0.557 . . . . 0.0 111.463 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.5 mt -57.94 -39.71 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.004 1.321 . . . . 0.0 110.978 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 mmt -62.03 -38.3 88.18 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.27 -0.894 . . . . 0.0 113.395 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.9 mt -65.31 -53.86 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.009 0.924 . . . . 0.0 110.459 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.2 m -68.33 -22.07 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.56 -26.22 59.42 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.869 1.7 . . . . 0.0 114.402 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.9 8.66 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 118.673 1.236 . . . . 0.0 111.232 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -57.3 9.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.765 1.626 . . . . 0.0 113.381 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.79 -34.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.76 -26.86 58.31 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.521 1.058 . . . . 0.0 114.215 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -41.22 76.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.924 1.362 . . . . 0.0 111.534 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -59.8 -44.08 94.16 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.853 0.861 . . . . 0.0 112.629 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.3 mt -65.64 -51.82 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.213 1.405 . . . . 0.0 109.566 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.32 -43.12 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.922 1.289 . . . . 0.0 111.752 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.32 -42.65 99.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.303 1.041 . . . . 0.0 112.353 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.1 97.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.525 -0.734 . . . . 0.0 111.715 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.07 -35.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.588 1.155 . . . . 0.0 111.716 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.0 -45.23 78.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.673 -1.267 . . . . 0.0 110.754 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.0 m -62.72 -47.43 83.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.386 1.074 . . . . 0.0 112.472 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.9 tt -66.82 -35.75 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 118.962 0.801 . . . . 0.0 112.571 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -59.87 -24.48 64.28 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.087 1.312 . . . . 0.0 113.461 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -71.11 -30.25 66.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.99 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -160.95 . . . . . . . . 1 1 . 1 stop_ save_